( (TITLE (FRAG (NP (NP (JJ Spontaneous) (NN Autoimmunity)) (PP-LOC (IN in) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS Mice)))) (: —) (NP (NP (NP (NNS Implications)) (PP (IN for) (NP (NN Autoimmunity)))) (VP (VBN Described) (NP (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NN Gene) (HYPH -) (VBN Targeted)) (NNS Mice))))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ (NP (JJ Systemic) (NN lupus) (NN erythematosus)) (NP (-LRB- -LRB-) (NN SLE) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ multisystem) (JJ autoimmune) (NN disorder)) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ (JJ complex) (JJ genetic) (NNS factors)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP-1 (-NONE- *T*))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Several) (NNS strains)) (PP (IN of) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB develop) (NP (NN SLE))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG implicating) (NP (DT the) (JJ null) (NNS genes)) (PP-LOC (IN in) (NP (NP (DT the) (NN causation)) (PP (IN of) (NP (NN disease)))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (NP (JJ hybrid) (NNS strains)) (PP (IN between) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice)))) (, ,) (VP (ADVP (RB widely)) (VBN used) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice))))))) (, ,) (VP (VBP develop) (NP (JJ spontaneous) (NN autoimmunity))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (DT the) (JJ genetic) (NN background)) (ADVP (RB markedly)) (VP (VBZ influences) (NP (NP (DT the) (JJ autoimmune) (NN phenotype)) (PP (IN of) (NP (NN SLE)))) (PP-LOC (IN in) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice)))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ suggests) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN autoimmunity))) (PP (IN of) (NP (NP (ADJP (ADVP (RB as) (HYPH -) (RB yet)) (HYPH -) (JJ uncharacterised)) (NN background) (NNS genes)) (VP (VBG originating) (PP (IN from) (NP (DT these) (JJ parental) (NN mouse) (NNS strains)))))))))) (. .)) )
( (S (S-MNR (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG Using) (NP (ADJP (NN genome) (HYPH -) (JJ wide)) (NN linkage) (NN analysis)))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD identified) (NP (NP (NP (JJ several) (NN susceptibility) (NNS loci)) (, ,) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice))))) (, ,) (VP (VBN mapped) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (ADJP (NN lupus) (HYPH -) (JJ prone)) (NN hybrid) (PRN (-LRB- -LRB-) (NP (NP (CD 129)) (SYM ×) (NP (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-)) (NN model)))))) (. .)) )
( (S (PP-MNR (IN By) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG creating) (NP (NP (DT a) (NML (NN C57BL) (HYPH /) (CD 6)) (JJ congenic) (NN strain)) (VP (VBG carrying) (NP (DT a) (ADJP (CD 129) (HYPH -) (VBN derived)) (NML (NN Chromosome) (CD 1)) (NN segment))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-2 (DT this) (CD 129) (NN interval)) (VP (VBD was) (ADJP-PRD (JJ sufficient) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB mediate) (NP (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (NN tolerance)) (PP (IN to) (NP (JJ nuclear) (NNS antigens)))))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD had) (ADVP-TMP (RB previously)) (VP (VBN been) (VP (VBN attributed) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT a) (VBN disrupted) (NN gene))))))))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VBP demonstrate) (NP (NP (JJ important) (JJ epistatic) (NNS modifiers)) (PP (IN of) (NP (NP (NP (NN autoimmunity)) (PP-LOC (IN in) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NN mouse) (NNS strains)))) (, ,) (VP (ADVP (RB widely)) (VBN used) (NP (-NONE- *)) (PP (IN in) (NP (NN gene) (NN targeting)))))))) (. .)) )
( (S (NP-SBJ (DT These) (NN background) (NN gene) (NNS influences)) (VP (MD may) (VP (VB account) (PP (IN for) (NP (NP (NP (DT some)) (, ,) (CC or) (NP (RB even) (DT all))) (, ,) (PP (IN of) (NP (NP (DT the) (JJ autoimmune) (NNS traits)) (VP (VBN described) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT some) (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS models)) (PP (IN of) (NP (NN SLE)))))))))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (NP-SBJ (NP (JJ Systemic) (NN lupus) (NN erythematosus)) (-LRB- -LRB-) (NP (NN SLE)) (-RRB- -RRB-)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ chronic) (JJ autoimmune) (NN disease)) (VP (VBN characterised) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NNS autoantibodies)) (-LRB- -LRB-) (NP (NNS auto-Abs)) (-RRB- -RRB-))) (PP (IN against) (NP (NP (DT a) (JJ wide) (NN spectrum)) (PP (IN of) (NP (NP (NN self) (HYPH -) (NNS antigens)) (, ,) (PP (ADVP (RB mainly)) (IN from) (NP (NP (JJ subcellular) (NNS compartments)) (, ,) (NP (ADVP (RB especially)) (DT the) (NN cell) (NN nucleus))))))))))))) (. .)) )
( (S (NP-SBJ (JJ Genetic) (NN predisposition)) (VP (VBZ is) (NP-PRD (NP (DT an) (JJ important) (NN contributor)) (PP (IN to) (NP (NP (NN susceptibility)) (PP (IN to) (NP (NN SLE)))))) (PP-LOC (IN in) (NP (CC both) (NNS humans) (CC and) (NNS animals))) (CIT (-LRB- -LRB-) (NNP Vyse) (CC and) (NNP Todd) (CD 1996) (: ;) (NNP Harley) (FW et) (FW al.) (CD 1998) (: ;) (NNP Theofilopoulos) (CC and) (NNP Kono) (CD 1999) (: ;) (NNP Wakeland) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (NP (NNS Genes)) (PP-LOC (IN in) (NP (JJ multiple) (NNS pathways)))) (VP (VBP participate) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG mediating) (NP (NN disease) (NN pathogenesis))))))) (, ,) (CC and) (S (NP-SBJ (NP (JJ epistatic) (NNS interactions)) (PP (IN amongst) (NP (DT these) (NNS genes)))) (VP (VBP influence) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN disease)))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN context))) (, ,) (NP-SBJ-1 (CC both) (NP (NP (NML (JJ genetic) (NN linkage)) (NNS studies)) (PP-LOC (IN in) (NP (JJ spontaneous) (ADJP (NN lupus) (HYPH -) (JJ prone)) (NNS models)))) (CC and) (NP (NP (NP (JJ synthetic) (JJ murine) (NNS models)) (PP (IN of) (NP (NN autoimmunity)))) (VP (VBN generated) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (VBN targeted) (NN disruption)) (PP (IN of) (NP (NP (JJ specific) (NNS genes)) (VP (VBG modulating) (NP (DT the) (JJ immune) (NN system)))))))))) (VP (VBP have) (ADVP (RB widely)) (VP (VBN been) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN complexity)) (PP (IN of) (NP (NN SLE)))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (ADJP (RBS best) (HYPH -) (VBN studied)) (NNS strains)) (PP (IN of) (NP (NP (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP-TMP (RB spontaneously)) (VP (VBP develop) (NP (DT a) (ADJP (NN lupus) (HYPH -) (JJ like)) (NN pathology)))))))) (VP (VBP are) (NP-PRD (NP (DT the) (NML (NML (NML (NNP New) (NNP Zealand)) (NN Black)) (HYPH /) (NML (NML (NNP New) (NNP Zealand)) (NN White))) (NN hybrid) (NN strain) (PRN (-LRB- -LRB-) (NP (NN NZB) (HYPH /) (NN WF1)) (-RRB- -RRB-))) (: ;) (NP (NP (DT the) (NML (NN MRL) (HYPH /) (NN Mp)) (NML (NN lpr) (HYPH /) (NN lpr)) (NN strain)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ carries) (NP (NP (DT the) (NN lpr) (NN mutation)) (PP (IN of) (NP (DT the) (NML (NN FAS) (NN receptor)) (NN gene)))))))) (: ;) (CC and) (NP (NP (DT the) (NN BXSB) (NN strain)) (, ,) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ carries) (NP (DT the) (NML (NML (NML (NN Y) (NN chromosome)) (JJ autoimmune) (NN accelerator)) (-LRB- -LRB-) (NML (NNP Yaa)) (-RRB- -RRB-)) (NN gene) (CIT (-LRB- -LRB-) (NNP Theofilopoulos) (CC and) (NNP Dixon) (CD 1985) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Extensive) (NML (JJ genetic) (NN mapping)) (NNS studies)) (PP-LOC (IN in) (NP (DT all) (CD three) (NNS strains)))) (VP (VBP have) (VP (VBN identified) (NP (NP (JJ multiple) (NNS intervals)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NN disease) (NN susceptibility))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (DT the) (NNS intervals)) (VP (VBN detected) (NP (-NONE- *)))))) (VP (VBP are) (ADJP-PRD (NN strain) (HYPH -) (JJ specific)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG confirming) (NP (NP (DT the) (JJ genetic) (NN complexity)) (PP (IN of) (NP (DT the) (NN disease))))) (CC and) (VP (VBG indicating) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ extensive) (NN heterogeneity)))) (PP-LOC (IN in) (NP (NP (DT the) (NNS genes)) (VP (VBG contributing) (PP (IN to) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (DT the) (NN disease)))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (DT some) (NN susceptibility) (NNS loci)) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (JJ similar) (NN chromosome) (NNS locations)) (PP-LOC (IN in) (NP (JJ different) (NNS strains))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ-2 (ADVP (RB at) (RBS least)) (DT some) (NN susceptibility)) (VP (MD may) (VP (VB be) (VP (VBN shared) (NP-2 (-NONE- *)) (PP (IN amongst) (NP (ADJP (NN lupus) (HYPH -) (JJ prone)) (NNS strains))))))))))))) (. .)) )
( (S (PP (IN Amongst) (NP (DT these) (VBN shared) (NN susceptibility) (NNS loci))) (, ,) (NP-SBJ (DT the) (RBS most) (JJ striking)) (VP (VBP are) (NP-PRD (NP (NP (NNS loci)) (PP-LOC (IN on) (NP (JJ distal) (NN Chromosome) (CD 1)))) (, ,) (SBAR (WHPP-3 (IN for) (WHNP (WDT which))) (S (NP-SBJ-1 (JJ important) (VBG contributing) (NNS genes)) (VP (VBP have) (VP (VBN been) (VP (VBN found) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NNP New) (NNP Zealand)) (CC and) (NML (NN BXSB))) (NNS models))) (PP-3 (-NONE- *T*)) (CIT (-LRB- -LRB-) (NNP Theofilopoulos) (CC and) (NNP Kono) (CD 1999) (: ;) (NNP Wakeland) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (JJ considerable) (NNS efforts) (S-4 (-NONE- *ICH*))) (VP (VBP have) (VP (VBN been) (VP (VBN made) (NP-1 (-NONE- *)) (S-4 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NNS genes)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT the) (NN disease))))))))))))))) (, ,) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (DT the) (NN lpr) (NN mutation))))) (, ,) (NP-SBJ-2 (NP (NN none)) (PP (IN of) (NP (NP (DT the) (JJ genetic) (NNS contributions)) (PP (IN to) (NP (NN disease))) (PP-LOC (IN in) (NP (DT the) (CD three) (ADJP (RB well) (HYPH -) (VBN documented)) (JJ murine) (NN SLE) (NNS strains)))))) (VP (VBP have) (ADVP-TMP (RB yet)) (VP (VBN been) (ADVP (RB fully)) (VP (VBN resolved) (NP-2 (-NONE- *)) (PP (IN at) (NP (DT the) (NML (JJ molecular) (CC or) (NN protein)) (NN level)))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ-1 (NP (VBN targeted) (JJ genetic) (NN disruption)) (PP (IN of) (NP (NP (NN candidate) (NNS genes)) (VP (VBG encoding) (NP (NP (NN proteins)) (PP (IN of) (NP (DT the) (JJ immune) (NN system)))))))) (VP (VBZ has) (VP (VBN been) (ADVP (RB extensively)) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB examine) (NP (NP (PRP$ their) (NN role)) (PP (IN in) (NP (JJ immune) (NN regulation)))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (ADJP (RBS most) (JJ surprising)) (NN result)) (PP (IN of) (NP (DT this) (JJ powerful) (NN approach)))) (VP (VBZ has) (VP (VBN been) (NP-PRD (NP (DT the) (JJ high) (NN frequency)) (SBAR (WHPP-1 (IN with) (WHNP (WDT which))) (S (NP-SBJ-2 (JJ such) (NNS mutations)) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (NP-2 (-NONE- *)) (PP (IN with) (NP (DT an) (JJ autoimmune) (NN phenotype))) (PP-1 (-NONE- *T*)))))))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (PP-PRD (IN of) (NP (NN note))) (SBAR-1 (IN that) (S (NP-SBJ (NP (NP (JJ hybrid) (NNS strains)) (PP (IN between) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice)))) (, ,) (VP (ADVP (RB widely)) (VBN used) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice))))))) (, ,) (VP (VBP are) (ADVP-MNR (RB spontaneously)) (ADJP-PRD (VBN predisposed) (PP (IN to) (NP (NP (NN development)) (PP (IN of) (NP (NP (JJ humoral) (NN autoimmunity)) (PP (IN with) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN glomerulonephritis)))))))))) (CIT (-LRB- -LRB-) (NNP Obata) (FW et) (FW al.) (CD 1979) (: ;) (NNP Botto) (FW et) (FW al.) (CD 1998) (: ;) (NNP Bickerstaff) (FW et) (FW al.) (CD 1999) (: ;) (NNP Santiago) (HYPH -) (NNP Raber) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (DT the) (JJ genetic) (NN background)) (ADVP (RB markedly)) (VP (VBZ influences) (NP (DT the) (JJ autoimmune) (NN phenotype)) (PP-LOC (IN in) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice))) (CIT (-LRB- -LRB-) (NNP Bolland) (CC and) (NNP Ravetch) (CD 2000) (: ;) (NNP Santiago) (HYPH -) (NNP Raber) (FW et) (FW al.) (CD 2001) (: ;) (NNP Mitchell) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT These) (NNS observations)) (VP (VBD led) (PP (IN to) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ autoimmune) (NN phenotype)) (VP (VBN described) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT some) (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice))))) (VP (MD might) (VP (VB be) (PP-PRD (IN due) (RB primarily) (IN to) (NP (NP (NP (NNS combinations)) (PP (IN of) (NP (NP (ADJP (ADVP (RB as) (HYPH -) (RB yet)) (HYPH -) (JJ uncharacterised)) (NN background) (NNS genes)) (, ,) (VP (VBG originating) (PP (IN from) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice) (NNS strains))))))) (, ,) (VP (VP (VP (VBG interacting)) (CC or) (VP (FRAG (RB not)))) (PP-2 (IN with) (NP (DT the) (VBN mutated) (NN allele))))))))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB test) (NP (DT this))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD conducted) (NP (NP (DT a) (ADJP (NN genome) (HYPH -) (JJ wide)) (NN scan) (NN analysis)) (PP (IN of) (NP (NP (NP (CD two) (JJ large) (NNS cohorts)) (PP (IN of) (NP (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2) (NNS mice)))) (, ,) (SBAR (WHNP-1 (NP (CD one)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD carried) (NP (DT a) (NN mutation)) (PP-LOC (IN in) (NP (DT the) (NML (NN serum) (NN amyloid) (NN P) (NN component)) (NN gene) (PRN (-LRB- -LRB-) (NP (NN Apcs)) (-RRB- -RRB-))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (ADJP (NN Apcs) (HYPH -) (JJ deficient)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN Apcs) (SYM −) (HYPH /) (SYM −)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN chosen) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT an) (NN example)) (PP (IN of) (NP (NP (DT a) (ADJP (NN gene) (HYPH -) (VBN targeted)) (NN strain)) (VP (ADVP-TMP (RB previously)) (VBN reported) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB develop) (NP (DT a) (ADJP (NN lupus) (HYPH -) (JJ like)) (NN disease)) (PP-LOC (IN on) (NP (DT the) (NN hybrid) (JJ genetic) (NN background) (-LRB- -LRB-) (NML (CD 129) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-)))))))))))))) (: ;) (S (NP-SBJ (NP (NN autoimmunity)) (PP-LOC (IN in) (NP (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice)))) (VP (VBZ persists) (PP-TMP (ADVP (RB even)) (IN after) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG backcrossing) (NP (DT the) (VBN mutated) (NN gene)) (PP (IN onto) (NP (NN C57BL) (HYPH /) (CD 6))) (CIT (-LRB- -LRB-) (NNP Bickerstaff) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD chose) (NP (DT this) (VBN targeted) (NN gene)) (PP (IN in) (ADJP (JJ particular))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB study)))) (SBAR-PRP (IN since) (S (NP-SBJ-3 (DT the) (NN Apcs) (NN gene)) (VP (VBZ is) (VP (VBN located) (NP-3 (-NONE- *)) (PP (IN on) (NP (NP (NN Chromosome) (CD 1)) (, ,) (PP (NP-ADV (QP (RB approximately) (CD 94)) (NN cM)) (IN from) (NP (DT the) (NN centromere))) (, ,) (PP-LOC (IN within) (NP (NP (DT a) (NN region)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ-4 (NP (JJ several) (NML (NN lupus) (HYPH -) (NN susceptibility)) (NNS loci)) (, ,) (VP (VBN designated) (NP-1 (-NONE- *)) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (NP-PRD (NP (NN Sle1) (CIT (-LRB- -LRB-) (NNP Morel) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (, ,) (NP (NN Nba2) (CIT (-LRB- -LRB-) (NNP Drake) (FW et) (FW al.) (CD 1995) (: ;) (NNP Vyse) (FW et) (FW al.) (CD 1997) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN Bxs3) (CIT (-LRB- -LRB-) (NNP Hogarth) (FW et) (FW al.) (CD 1998) (: ;) (NNP Haywood) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))))))) (, ,) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (NP-4 (-NONE- *)) (PP (IN in) (NP (NML (NN NZW) (, ,) (NN NZB) (, ,) (CC and) (NN BXSB)) (ADJP (NN lupus) (HYPH -) (JJ prone)) (NNS strains))) (, ,) (ADVP (RB respectively)) (ADVP-LOC-2 (-NONE- *T*)))))))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN region)) (VP (VBZ contains) (NP (NP (JJ several) (NNS genes)) (, ,) (PP (VBG including) (NP (NP (NP (DT those)) (VP (VBG encoding) (NP (NN FcγRII)))) (, ,) (NP (NP (NP (NP (DT the) (NN complement) (NN receptor)) (NP (NP (NN CR1) (HYPH /) (CD 2)) (-LRB- -LRB-) (NP (NN CD35) (HYPH /) (NN CD21)) (-RRB- -RRB-))) (, ,) (CC and) (NP (DT the) (ADJP (NN decay) (HYPH -) (VBG accelerating)) (NN factor) (NN CD55)) (CIT (-LRB- -LRB-) (NNP Prodeus) (FW et) (FW al.) (CD 1998) (: ;) (NNP Bolland) (CC and) (NNP Ravetch) (CD 2000) (: ;) (NNP Miwa) (FW et) (FW al.) (CD 2002) (: ;) (NNP Wu) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP have) (NP-ADV (DT each)) (VP (VBN been) (VP (VBN implicated) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN causation)) (PP (IN of) (NP (NN SLE))))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN inactivated) (NP-3 (-NONE- *)) (PP-MNR (IN by) (NP (NN gene) (HYPH -) (VBG targeting))) (PP-LOC (IN in) (NP (CD 129) (JJ embryonic) (NN stem) (NNS cells))) (ADVP-TMP-2 (-NONE- *T*))))))))))))))) (. .)) )
( (S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (NP (JJ multiple) (JJ genetic) (NNS loci)) (, ,) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NML (CC both) (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice))))) (, ,) (VP (VBG contributing) (PP (IN to) (NP (NN autoimmunity))))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-1 (NP (DT a) (ADJP (CD 129) (HYPH -) (VBN derived)) (NN interval)) (PP-LOC (IN on) (NP (JJ distal) (NN Chromosome) (CD 1)))) (, ,) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN transferred) (NP-1 (-NONE- *)) (PP-LOC (IN onto) (NP (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN genome)) (, ,) (NP (NP (DT a) (NN combination)) (VP (ADVP (RB commonly)) (VBN created) (NP (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG backcrossing) (PP (IN onto) (NP (NN C57BL) (HYPH /) (CD 6))) (NP (NP (DT a) (NN gene)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ has) (VP (VBN been) (VP (VBN inactivated) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (CD 129) (JJ embryonic) (NN stem) (NNS cells)))))))))))))))) (ADVP-TMP-2 (-NONE- *T*))))) (, ,) (VP (VBD was) (ADJP-PRD (JJ sufficient) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB cause) (NP (JJ humoral) (NN autoimmunity)) (PP (IN in) (NP (PRP$ its) (JJ own) (NN right))) (, ,) (ADVP (RB irrespective) (PP (IN of) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (VBN mutated) (NN Apcs) (NN gene))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VP (VBP demonstrate) (NP (NP (JJ important) (JJ epistatic) (NNS interactions)) (PP (IN between) (NP (NP (NNS genes)) (PP (IN from) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS genomes))))) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN autoimmunity))))))) (CC and) (VP (VBP illustrate) (NP (NP (DT the) (JJ important) (NNS effects)) (PP (IN of) (NP (NN background) (NNS genes)))) (PP (IN in) (NP (NP (DT the) (NML (NN analysis) (CC and) (NN interpretation))) (PP (IN of) (NP (NP (JJ autoimmune) (NNS phenotypes)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (VBN targeted) (JJ genetic) (NNS disruptions)))))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NN Disease) (NNS Traits)) (PP-LOC (IN in) (NP (-LRB- -LRB-) (NML (NML (NML (NML (CD 129)) (SYM ×) (NP (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (CC and) (-LRB- -LRB-) (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2))) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS Mice))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (JJ genetic) (NN basis)) (PP (IN of) (NP (NP (DT the) (ADJP (NN lupus) (HYPH -) (JJ like)) (NN disease)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN hybrid) (NNS mice)))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VP (VBD generated) (NP (NP (NP (CD two) (JJ large) (NNS cohorts)) (PP (IN of) (NP (NML (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (NNS animals)))) (, ,) (NP (NP (CD one)) (VP (VBG carrying) (NP (DT a) (NN mutation)) (PP-LOC (IN in) (NP (DT the) (NN Apcs) (NN gene))))))) (, ,) (CC and) (VP (VBD monitored) (NP (PRP them)) (PP-TMP (IN for) (NP (CD 1) (NN y))) (PP (IN under) (NP (JJ identical) (JJ environmental) (NNS conditions))))) (. .)) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ (JJ female) (NNS mice)) (PP-LOC (IN in) (NP (DT the) (JJ original) (NNS reports))) (VP (VBD showed) (NP (NP (DT a) (JJR higher) (NN penetrance)) (PP (IN of) (NP (NN disease))))))) (, ,) (NP-SBJ-1 (DT the) (JJ present) (NN study)) (VP (VBD was) (VP (VBN conducted) (NP-1 (-NONE- *)) (ADVP (RB only)) (PP (IN on) (NP (JJ female) (NNS mice))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS results)) (PP (IN of) (NP (DT the) (JJ phenotypic) (NN analysis))) (PP-TMP (IN at) (NP (NP (CD 1) (NN y)) (PP (IN of) (NP (NN age)))))) (VP (VBP are) (VP (VBN summarised) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNS Tables) (NML (CD 1) (CC and) (CD 2)))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN reported) (NP-1 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP Botto) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))))) (, ,) (NP-SBJ (DT the) (NML (JJ wild) (HYPH -) (NN type)) (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2) (NNS mice)) (VP (VBD developed) (NP (NP (NP (NN lupus) (NNS traits)) (PP (IN with) (NP (NP (NP (VBN elevated) (NNS levels)) (PP (IN of) (NP (NNS auto-Abs)))) (, ,) (VP (VBG starting) (PP-TMP (IN from) (NP (NP (CD 6) (NN mo)) (PP (IN of) (NP (NN age))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))))) (, ,) (CC and) (NP (NP (JJ histological) (NN evidence)) (PP (IN of) (NP (JJ proliferative) (NN glomerulonephritis)))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (PRP$ our) (JJ previous) (NNS observations) (CIT (-LRB- -LRB-) (NNP Bickerstaff) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)))))) (, ,) (NP-SBJ (NP (DT the) (NNS titres)) (PP (IN of) (NP (NP (NP (JJ anti-nuclear) (NNS Abs)) (-LRB- -LRB-) (NP (NNS ANAs)) (-RRB- -RRB-)) (CC and) (NP (JJ anti-chromatin) (NN Ab))))) (VP (VBD were) (ADJP-PRD (RB considerably) (JJR greater)) (PP-LOC (IN in) (NP (DT the) (-LRB- -LRB-) (NML (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice))) (PP (VBN compared) (PP (IN with) (NP (DT the) (ADJP (NN strain) (HYPH -) (VBN matched)) (NNS controls))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (IN to) (NP (PRP$ our) (JJ original) (NNS findings))))) (, ,) (NP-SBJ (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (DT the) (JJ other) (CD two) (NN disease) (JJ serological) (NNS markers)) (VP (VBN analysed) (NP (-NONE- *))) (PRN (-LRB- -LRB-) (NP (NML (NML (NML (ADJP (VBN anti-single) (HYPH -) (VBN stranded)) (NN DNA)) (-LRB- [) (NML (NN ssDNA)) (-RRB- ])) (CC and) (NML (NML (ADJP (VBN anti-double) (HYPH -) (VBN stranded)) (NN DNA)) (-LRB- [) (NML (NN dsDNA)) (-RRB- ]))) (NNS Abs)) (-RRB- -RRB-))))) (CC and) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT the) (JJ renal) (NN pathology))))) (VP (VBD were) (RB not) (ADJP-PRD (JJ different)) (PP (IN between) (NP (DT the) (CD two) (JJ experimental) (NNS groups)))) (. .)) )
( (S (PP (IN In) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NP (DT the) (VBN fixed) (ADJP (CD 129) (HYPH -) (VBN derived)) (NN segment)) (VP (VBG flanking) (NP (DT the) (VBN mutated) (NN Apcs) (NN gene)))) (CC and) (NP (NP (DT the) (JJ autoimmune) (NNS traits)) (VP (VBN observed) (NP (-NONE- *)))))))))))) (, ,) (NP-SBJ-1 (NP (DT the) (ADJP (NN genome) (HYPH -) (JJ wide)) (NN linkage) (NN analysis)) (PP (IN of) (NP (DT the) (CD two) (JJ experimental) (NNS cohorts)))) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (ADVP-MNR (RB separately)))) (. .)) )
( (HEADING (NP (NP (NN Mapping)) (PP (IN of) (NP (NP (NNS Loci)) (VP (VBG Predisposing) (PP (IN to) (NP (NN Lupus)))))) (PP-LOC (IN in) (NP (NP (DT the) (NN Hybrid) (NN Strain)) (-LRB- -LRB-) (NP (NP (CD 129)) (SYM ×) (NP (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-))))) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN genotyped) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (CD 143) (NN microsatellite) (NNS markers)) (VP (VBN distributed) (NP (-NONE- *)) (PP (IN throughout) (NP (DT the) (NNS autosomes)))))) (SBAR-ADV (JJ such) (IN that) (S (NP-SBJ (NP (CD 98) (NN %)) (PP (IN of) (NP (DT the) (NNS genes)))) (VP (VBD were) (PP-PRD (IN within) (NP (NP (CD 20) (NNS cM)) (PP (IN of) (NP (DT an) (JJ informative) (NN marker)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN summary)) (PP (IN of) (NP (DT the) (ADJP (NN genome) (HYPH -) (JJ wide)) (NN linkage) (NN analysis))) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (NP (DT the) (NN disease) (NNS traits)) (VP (VBN measured) (NP (-NONE- *)))))))) (VP (VBZ is) (VP (VBN shown) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN Table) (CD 3))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS areas)) (PP (IN of) (NP (NN linkage)))) (VP (VBD were) (VP (VBN defined) (NP-1 (-NONE- *)) (PP (VBG according) (PP (IN to) (NP (NP (DT the) (JJ parental) (NN origin)) (, ,) (NP (NP (CD 129)) (CC or) (NP (NN C57BL) (HYPH /) (CD 6)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (RB Only) (NNS linkages)) (VP (VBN identified) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT both) (JJ experimental) (NNS groups))))) (VP (VBP are) (VP (VBN reported) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN Table) (CD 3))) (, ,) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NP (DT the) (NML (NN Chromosome) (CD 1)) (JJ distal) (NN segment)) (, ,) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (DT the) (NN linkage) (NN analysis)) (VP (MD could) (RB not) (VP (VB be) (VP (VBN applied) (NP-2 (-NONE- *)) (PP (IN to) (NP (DT the) (NML (-LRB- -LRB-) (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice))) (SBAR-PRP (IN as) (S (NP-SBJ (DT this) (NN region)) (VP (VBD was) (PP-PRD (IN of) (NP (VBN fixed) (CD 129) (NN origin)))))) (ADVP-LOC-3 (-NONE- *T*))))))))))))) (. .)) )
( (S (NP-SBJ-2 (NP (NNS Chromosomes)) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (NNS linkages)) (VP (VBD were) (ADJP-PRD (JJ present)) (PP-LOC (ADVP (RB only)) (IN in) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (CD two) (NNS cohorts))))) (ADVP-LOC-1 (-NONE- *T*)))))) (VP (VBP are) (VP (VBN shown) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NNS Figures) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 3)))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NML (NML (JJ quantitative) (NN trait) (NN linkage)) (-LRB- -LRB-) (NML (NN QTL)) (-RRB- -RRB-)) (NN analysis)) (VP (VBD identified) (NP (NP (JJ several) (NNS intervals)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 1))) (PP (IN with) (NP (NP (NN linkage)) (PP (IN to) (NP (NN disease) (JJ serological) (NNS markers)))))))) (, ,) (CC and) (S (NP-SBJ-1 (DT these) (NNS regions)) (VP (VBD were) (RB all) (VP (VBN derived) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (CD 129) (NN mouse) (NN strain))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Table) (CD 3)))) (: ;) (NP (NNS Figures) (NML (CD 4) (CC and) (CD 5))) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (SBAR-ADV (IN whilst) (S (NP-SBJ (NML (NML (NN ANA)) (CC and) (NML (JJ anti-chromatin) (NN Ab))) (NNS levels)) (VP (VBD showed) (NP (NP (ADJP (JJ suggestive) (CC or) (JJ significant)) (NNS linkages)) (PP (ADVP (RB only)) (IN to) (NP (NP (DT the) (JJ telomeric) (NN region)) (PP (IN of) (NP (NN Chromosome) (CD 1))))) (, ,) (PP (IN with) (S-NOM (NP-SBJ (DT an) (VBN estimated) (NN peak)) (VP (VBG occurring) (PP-LOC (IN at) (NP (NP (DT a) (NN position)) (PP (NP-ADV (QP (RB approximately) (CD 90)) (NN cM)) (IN near) (NP (DT the) (NN Apcs) (NN gene)))))))))))) (, ,) (NP-SBJ-1 (ADJP (JJ anti-dsDNA) (CC or) (JJ anti-ssDNA)) (NN Ab) (NN production)) (VP (VBD was) (ADVP (RB also)) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (JJ other) (NNS segments)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 1))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (NP (DT a) (ADJP (RBR more) (JJ complex)) (JJ genetic) (NN contribution)) (PP (IN from) (NP (DT the) (CD 129) (NN mouse) (NN strain))))))) (. .)) )
( (S (S-ADV (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN Guided) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (DT these) (NNS observations))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP-SBJ-1 (NP (NP (DT the) (VBN increased) (NNS levels)) (PP (IN of) (NP (NN ANA) (CC and) (JJ anti-chromatin) (NN Ab)))) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice))))) (VP (VBD were) (VP (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN gene) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (PP-LOC (IN within) (NP (NP (DT the) (VBN fixed) (CD 129) (NN region)) (VP (VBG surrounding) (NP (DT the) (VBN mutated) (NN Apcs) (NN gene)))))))) (, ,) (CONJP (RB rather) (IN than)) (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (VBN mutated) (NN Apcs) (NN gene)) (NP (PRP itself)))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (DT these) (NNS auto-Abs))) (PP (IN between) (NP (NP (DT all) (-LRB- -LRB-) (NML (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (CC and) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (CD 33) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN selected) (NP-1 (-NONE- *)) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG being) (NP-PRD (JJ homozygous) (CD 129)) (PP-LOC (IN in) (NP (NP (DT the) (NN region)) (PP (IN of) (NP (NN Chromosome) (CD 1))) (PP (IN between) (NP (NNS microsatellites) (NML (NML (NN D1Mit105)) (CC and) (NML (NN D1Mit) (CD 223))))) (PRN (-LRB- -LRB-) (NP (QP (CD 80) (SYM –) (CD 106)) (NN cM)) (-RRB- -RRB-))))))))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NML (NN 6A)) (PP (SYM –) (NP (NN 6D))))) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NP (NN contrast)) (PP (IN to) (NP (NP (DT the) (NNS results)) (VP (VBN reported) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN Table) (CD 1)))))))) (, ,) (NP-SBJ (DT this) (NN comparison)) (VP (VBD showed) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN between) (NP (DT the) (CD two) (JJ experimental) (NNS groups))))) (. .)) )
( (S (NP-SBJ (DT This) (NN result)) (VP (VBZ demonstrates) (SBAR (IN that) (, ,) (S (ADVP (RBS most) (RB likely)) (, ,) (NP-SBJ (NP (DT the) (ADJP (CD 129) (HYPH -) (VBN derived)) (NN region)) (CONJP (CC and) (RB not)) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NN Apcs))))) (VP (VBD was) (VP (VBG mediating) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NN ANA)) (CC and) (NP (JJ anti-chromatin) (NN Ab)))))))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (DT this) (NN explanation))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (DT the) (CD 129) (NNS mice)) (VP (VBP have) (NP (NP (ADJP (RB significantly) (JJR higher)) (NNS levels)) (PP (IN of) (NP (NN Apcs))) (PP (IN in) (NP (NN circulation)))) (PP (VBN compared) (PP (IN with) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NNS mice))))))) (PRN (-LRB- -LRB-) (FRAG (FRAG (FRAG (NP (NN median)) (, ,) (NP (NP (CD 83) (NNS mg)) (PP (SYM /) (NP (NN l))))) (: ;) (FRAG (NP (NN range)) (, ,) (NP (NP (CD 25)) (PP (SYM –) (NP (CD 208))))) (: ;) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 16))))) (CC versus) (FRAG (FRAG (NP (NN median)) (, ,) (NP (NP (CD 5) (NN mg)) (PP (SYM /) (NP (NN l))))) (: ;) (FRAG (NP (NN range)) (, ,) (NP (NP (CD 4)) (PP (SYM –) (NP (CD 9))))) (: ;) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 10)) (, ,)))) (ADVP (RB respectively))) (: ;) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.0001)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN C57BL) (HYPH /) (CD 6)) (NN strain)) (VP (VBZ has) (ADVP-TMP (RB previously)) (VP (VBN been) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ murine) (NNS strains)) (VP (VBN defined) (NP (-NONE- *)) (PP (IN as) (NP (JJ low) (NN Apcs) (NNS producers)))))))))) (CIT (-LRB- -LRB-) (NNP Pepys) (FW et) (FW al.) (CD 1979) (: ;) (NNP Baltz) (FW et) (FW al.) (CD 1980) (-RRB- -RRB-))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (NP (NN sequence) (NN analysis)) (PP (IN of) (NP (DT the) (JJ entire) (NN Apcs) (VBG coding) (NN region))) (PP-LOC (IN in) (NP (DT both) (NNS strains)))) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB identify) (NP (DT any) (NML (VBG coding) (NN sequence)) (NNS polymorphisms)) (PP-LOC (IN in) (NP (DT the) (NN Apcs) (NN gene))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ structural) (NN variant)) (PP (IN of) (NP (DT the) (NN protein)))) (VP (VBZ is) (ADJP-PRD (JJ unlikely) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT the) (NN explanation)) (PP (IN for) (NP (PRP$ our) (NNS findings))))))))))))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ is) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (NP (DT a) (JJ previous) (NN report)) (PP (IN by) (NP (NP (NNP Drake)) (ADVP-ETC (FW et) (FW al.)) (-LRB- -LRB-) (NP-TMP (CD 1996)) (-RRB- -RRB-)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD showed) (NP (DT no) (NML (NN Apcs) (VBG coding) (NN sequence)) (NNS differences)) (PP (IN amongst) (NP (JJ several) (ADJP (JJ autoimmune) (CC and) (JJ nonautoimmune)) (JJ murine) (NNS strains)))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (DT the) (ADJP (CD 129) (HYPH -) (VBN derived)) (NNS segments))))) (, ,) (PP-LOC (IN in) (NP (DT both) (NNS cohorts))) (NP-SBJ (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN strain)) (VP (VBD contributed) (PP (IN to) (NP (DT the) (JJ autoimmune) (NNS traits))) (PP (IN with) (NP (NP (CD one) (JJ major) (NN susceptibility) (NN locus)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 3)))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (JJ genomic) (NN region)) (PP (IN between) (NP (NN D3Mit40) (CC and) (NN D3Mit13))) (, ,) (PP (IN with) (NP (NP (DT an) (VBN estimated) (NN peak)) (PP (IN at) (NP (NN position) (QP (RB approximately) (CD 51)) (NNS cM)))))) (, ,) (VP (VBD showed) (NP (NP (NP (DT a) (JJ significant) (NN linkage)) (PP (IN to) (NP (NN ANA) (NN production)))) (CC and) (NP (NP (JJR weaker) (NNS linkages)) (PP (IN to) (NP (ADJP (JJ anti-ssDNA) (CC and) (JJ anti-chromatin)) (NN production)))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NP (NN Table) (CD 3)) (: ;) (NP-ADV (NN Figure) (CD 7))))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (NP (DT The) (JJ high) (NN frequency)) (PP (IN of) (NP (JJ autoimmune) (NN phenotype))) (PP-LOC (IN in) (NP (DT the) (-LRB- -LRB-) (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (JJ hybrid)) (JJ genetic) (NN background)))) (CC and) (NP (NP (PRP$ its) (NN absence)) (PP-LOC (IN in) (NP (NP (DT either)) (PP (IN of) (NP (DT the) (JJ inbred) (JJ parental) (NNS strains))))))) (VP (VBP imply) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (JJ essential) (NNS interactions)) (PP (IN between) (NP (ADJP (NP (NP (CD 129)) (HYPH -) (CC and) (NP (NN C57BL) (HYPH /) (CD 6)) (HYPH -)) (VBN derived)) (NNS alleles)))) (PP-PRP (IN for) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN autoimmunity))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD investigated) (ADVP (RB further)) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS genes)) (PP (IN from) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN background)))))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG repeating) (NP (DT the) (NN linkage) (NN analysis)) (PP-LOC (IN in) (NP (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2) (NNS mice))) (, ,) (SBAR-ADV (IN whilst) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG controlling) (PP (IN for) (NP (NP (DT the) (ADJP (RB very) (JJ strong)) (CD 129) (NN effect)) (PP (IN on) (NP (JJ distal) (NN Chromosome) (CD 1))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP Zeng) (CD 1994) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN analysis)))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ statistical) (NN support)) (PP (IN for) (NP (NP (DT the) (NN linkage)) (PP (IN of) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN locus))) (PP (IN on) (NP (NN Chromosome) (CD 3))) (PP (IN for) (NP (NN ANA)))))) (VP (VBD increased) (PP (PP (IN from) (NP (NML (NML (NML (NN logarithm)) (PP (IN of) (NP (NNS odds)))) (-LRB- -LRB-) (NML (NN LOD)) (-RRB- -RRB-)) (CD 5.4))) (PP (IN to) (NP (NN LOD) (CD 6.4)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN contrast)) (PP (IN to) (NP (NP (DT these) (JJ strong) (NNS associations)) (PP (IN with) (NP (NN disease) (JJ serological) (NNS markers))))))) (, ,) (NP-SBJ (DT the) (NN QTL) (NN analysis)) (VP (VBD identified) (NP (NP (NP (RB only) (CD two) (JJ potential) (NNS linkages)) (PP (IN to) (NP (NN glomerulonephritis)))) (: :) (NP (NP (NP (CD one)) (PP-LOC (IN in) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (PP-LOC (IN on) (NP (NN Chromosome) (CD 7))) (PP (IN across) (NP (NP (DT a) (NML (CD 10) (NN cM)) (NN region)) (PP (IN between) (NP (NP (NN D7Mit246) (PRN (-LRB- -LRB-) (NP (CD 15) (NN cM)) (-RRB- -RRB-))) (CC and) (NP (NN D7Mit145) (PRN (-LRB- -LRB-) (NP (CD 26.5) (NN cM)) (-RRB- -RRB-))))))) (PP (IN of) (NP (CD 129) (NN origin) (PRN (-LRB- -LRB-) (NP (NN LOD) (CD 2.86)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.0013)))) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (CD one)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 17))) (PP (IN between) (NP (NP (NN D17Mit100) (PRN (-LRB- -LRB-) (NP (CD 11.7) (NN cM)) (-RRB- -RRB-))) (CC and) (NP (NN D17Mit216) (PRN (-LRB- -LRB-) (NP (CD 29.4) (NN cM)) (-RRB- -RRB-))))) (PP (IN from) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN strain))) (PRN (-LRB- -LRB-) (FRAG (NP (NN LOD) (CD 1.3)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.049))))) (CC and) (FRAG (NP (NN LOD) (CD 1.67)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.021))))) (PP-LOC (IN in) (NP (DT the) (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice))) (, ,) (ADVP (RB respectively)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-2 (NP (JJ Histological) (NN evidence)) (PP (IN of) (NP (NN glomerulonephritis)))) (VP (VBD was) (ADVP (RB only)) (VP (VBN found) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NP (QP (RB approximately) (CD 20)) (NN %)) (PP (IN of) (NP (NP (DT the) (NNS mice)) (PP (IN in) (NP (DT each) (NN cohort))))))) (, ,) (SBAR-ADV (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ reduces) (NP (NP (DT the) (NN power)) (PP (IN of) (NP (DT the) (NN QTL) (NN analysis)))) (PP (IN for) (NP (DT this) (NN disease) (NN trait)))))))) (. .)) )
( (HEADING (NP (NP (NP (NN Production)) (PP (IN of) (NP (DT a) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (CD 129))) (NML (NN Chromosome) (CD 1)) (JJ Congenic) (NN Line)))) (CC and) (NP (PRP$ Its) (JJ Phenotypic) (NN Analysis)))) )
( (S (NP-SBJ (PRP We)) (VP (VBD generated) (NP (NP (DT a) (NML (NN C57BL) (HYPH /) (CD 6)) (JJ congenic) (NN line)) (VP (VBG carrying) (NP (NP (DT the) (JJ telomeric) (NN region)) (PP (IN of) (NP (NN Chromosome) (CD 1)))) (PP (IN from) (NP (DT the) (CD 129) (NN mouse) (NN strain))))) (, ,) (PP-PRP (IN in) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB dissect) (NP (NP (DT the) (JJ complex) (JJ polygenic) (NN disease) (NN phenotype)) (PP (IN of) (NP (DT the) (-LRB- -LRB-) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (SYM ×) (NML (NN 129) (HYPH /) (NN Sv))) (-RRB- -RRB-) (NN F2) (NN hybrid) (NN strain)))) (PP (IN into) (NP (PRP$ its) (JJ individual) (JJ genetic) (NNS components))))))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (CD 129) (NN interval)) (VP (VBD was) (VP (VBN backcrossed) (NP-1 (-NONE- *)) (NP-TMP (CD seven) (NNS times)) (PP (IN onto) (NP (NN C57BL) (HYPH /) (CD 6)))))) (, ,) (CC and) (S (PP (IN at) (NP (DT each) (NN generation))) (NP-SBJ-2 (NP (DT the) (NML (NN presence) (CC or) (NN absence))) (PP (IN of) (NP (DT the) (NML (NN Chromosome) (CD 1)) (NN interval)))) (VP (VBD was) (VP (VBN determined) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (JJ several) (NN microsatellite) (NNS markers)))))) (. .)) )
( (S (NP-SBJ-1 (DT Each) (VBN backcrossed) (NN generation)) (VP (VBD was) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (QP (JJR more) (IN than) (CD three)) (NNS markers)) (PP (IN per) (NP (NN chromosome))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB facilitate) (NP (NP (DT the) (NN removal)) (PP (IN of) (NP (JJ unselected) (CD 129) (JJ genomic) (NNS regions))))))))) (. .)) )
( (S (PP (IN At) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN backcrossing))))) (, ,) (NP-SBJ (NP (DT the) (ADJP (CD 129) (HYPH -) (VBN derived)) (NML (NN Chromosome) (CD 1)) (NN interval)) (PP-LOC (IN in) (NP (DT the) (JJ congenic) (NNS mice)))) (VP (VBN extended) (PP (PP (IN from) (NP (NP (NN microsatellite) (NN marker)) (NP (NN D1Mit105)))) (PP (IN to) (NP (NN D1Mit223) (PRN (-LRB- -LRB-) (NP (QP (CD 80) (SYM –) (CD 106)) (NNS cM)) (-RRB- -RRB-))))) (, ,) (SBAR-ADV (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ encompasses) (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (CD 129) (NN interval)) (VP (VBN identified) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN linkage) (NNS studies))) (PP-LOC (IN in) (NP (DT the) (-LRB- -LRB-) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (SYM ×) (NML (NN 129) (HYPH /) (NN Sv))) (-RRB- -RRB-) (NN F2) (NNS mice))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Female) (NML (NN Chromosome) (CD 1)) (JJ congenic) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN C57BL) (HYPH /) (CD 6) (HYPH .) (CD 129) (PRN (-LRB- [) (NP (NP (NN D1Mit105)) (PP (SYM –) (NP (CD 223)))) (-RRB- ]))) (-RRB- -RRB-)) (, ,) (PP (RB together) (PP (IN with) (NP (NP (NP (NP (ADJP (NN sex) (HYPH -) (VBN matched)) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (VP (VBN backcrossed) (NP (-NONE- *)) (PP (IN onto) (NP (NN C57BL) (HYPH /) (CD 6))) (PP-TMP (IN for) (NP (CD ten) (NNS generations))))) (-LRB- -LRB-) (NP (NP (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NP (NN Apcs) (SYM −) (HYPH /) (SYM −)))) (-RRB- -RRB-) (CC and) (NP (NML (NN C57BL) (HYPH /) (CD 6)) (NNS controls)))))) (, ,) (VP (VBD were) (VP (VBN monitored) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN lupus))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice))) (, ,) (NP-SBJ-1 (NP (DT the) (CD 129) (NN genome)) (PP-LOC (IN around) (NP (DT the) (NN Apcs) (NN locus)))) (VP (VBD was) (VP (VBN mapped) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (NP (DT a) (NN stretch)) (PP (IN of) (NP (QP (RB approximately) (CD 17)) (NN cM)))) (, ,) (VP (VBN positioned) (NP (-NONE- *)) (PP (PP (IN from) (NP (CD 87.9) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit15)) (-RRB- -RRB-)))) (PP (IN to) (NP (CD 105) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit17)) (-RRB- -RRB-)))))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (DT the) (JJ congenic) (NN line)) (VP (VBD carried) (NP (NP (DT a) (JJ similar) (CD 129) (NN region) (PRN (-LRB- -LRB-) (NP (QP (CD 80) (SYM –) (CD 106)) (NN cM)) (-RRB- -RRB-))) (PP (IN to) (NP (NP (DT the) (CD one)) (ADJP (JJ present) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice) (PRN (-LRB- -LRB-) (NP (QP (CD 87.9) (SYM –) (CD 105)) (NN cM)) (-RRB- -RRB-))))))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NP (CD 1) (NN y)) (PP (IN of) (NP (NN age))))) (, ,) (S (S (NP-SBJ-1=2 (DT all) (NNS animals)) (VP (VBD were) (VP=3 (VBN sacrificed) (NP-1 (-NONE- *))))) (, ,) (S (NP-SBJ-4=2 (DT the) (NNS auto-Abs)) (VP=3 (VBN assessed) (NP-4 (-NONE- *)))) (, ,) (CC and) (S (NP-SBJ-5=2 (DT the) (JJ renal) (NN histology)) (VP=3 (VBN examined) (NP-5 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN analysis)))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (CD 8))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN reported) (NP-2 (-NONE- *))))) (CIT (-LRB- -LRB-) (NNP Bickerstaff) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)) (, ,) (NP-SBJ-1 (NP (DT the) (NNS levels)) (PP (IN of) (NP (NNS auto-Abs)))) (VP (VBD were) (ADVP (RB markedly)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NML (NN C57BL) (HYPH /) (CD 6)) (NNS controls)))))) (. .)) )
( (S (S (ADVP (RB However)) (, ,) (NP-SBJ (DT the) (NML (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (CD 129)) (-LRB- -LRB-) (NML (NML (NN D1Mit105)) (PP (SYM –) (NP (CD 223))))) (-RRB- -RRB-) (NNS animals)) (ADVP (RB also)) (VP (VBD expressed) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NNS auto-Abs)))))) (, ,) (CC and) (S (NP-SBJ (DT these) (NNS titres)) (VP (VBD were) (RB not) (ADJP-PRD (JJ different) (PP (IN from) (NP (NP (DT those)) (VP (VBN detected) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (VBN matched) (JJ congenic) (NNS mice)) (VP (VBG containing) (NP (NP (DT a) (JJ null) (NN mutation)) (PP (IN of) (NP (DT the) (NN Apcs) (NN gene))))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (ADVP (RB clearly)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-1 (NP (JJ epistatic) (NNS interactions)) (PP (IN between) (NP (NP (NP (CD 129) (NNS loci)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 1)))) (CC and) (NP (NML (NN C57BL) (HYPH /) (CD 6)) (NNS genes))))) (VP (VBD were) (ADJP-PRD (JJ sufficient) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB mediate) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (NN tolerance)) (PP (IN to) (NP (JJ nuclear) (NNS autoantigens)))))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (IN to) (NP (DT the) (JJ serological) (NNS data))))) (, ,) (NP-SBJ (NP (DT the) (JJ histological) (NN assessment)) (PP (IN of) (NP (DT the) (NNS kidneys)))) (VP (VBD showed) (NP (NP (NN evidence)) (PP (IN of) (NP (RB markedly) (VBN increased) (NN glomerulonephritis))) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))))) (PP (VBN compared) (PP (IN to) (NP (CC both) (NN control) (NNS groups) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 9)) (-RRB- -RRB-)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NN lack)) (PP (IN of) (NP (NN Apcs)))) (, ,) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN combined) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ other) (NML (NN C57BL) (HYPH /) (CD 6)) (NN susceptibility) (NNS alleles))) (ADVP-TMP-2 (-NONE- *T*))))) (, ,) (VP (MD can) (VP (VB induce) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ severe) (JJ renal) (NN damage))))))))))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (VBG accumulating) (NN evidence) (SBAR (IN that) (S (NP-SBJ (NN background) (NNS genes)) (VP (MD may) (VP (VB influence) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN autoimmunity)))) (PP-LOC (IN in) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice))))))))) (. .)) )
( (S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP report) (SBAR (WHNP-1 (WP what)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (PP (IN to) (NP (PRP$ our) (NN knowledge))) (NP-PRD (NP (DT the) (JJ first) (JJ systematic) (NN study)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ has) (VP (VBN examined) (NP (DT this)) (PP-LOC (IN in) (NP (NP (DT the) (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NN mouse) (NNS strains)) (, ,) (VP (ADVP (RB widely)) (VBN used) (NP (-NONE- *)) (PP-PRP (IN for) (NP (NN gene) (NN targeting))))))))))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS results)) (VP (VBP demonstrate) (NP (NP (NP (VBG interacting) (NNS loci)) (PP (IN between) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD can) (VP (VB cause) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT a) (JJ powerful) (JJ autoimmune) (NN phenotype)))) (PP-LOC (IN in) (NP (DT these) (NNS animals))) (, ,) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT any) (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mutations))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VP (VBD developed) (NP (NP (DT a) (JJ congenic) (NN mouse) (NN strain)) (VP (VBG bearing) (NP (NP (DT a) (NN portion)) (PP (IN of) (NP (CD 129) (NN Chromosome) (CD 1)))) (PP-LOC (IN on) (NP (DT a) (NML (NN C57BL) (HYPH /) (CD 6)) (NN background)))))) (CC and) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (DT this) (NML (JJ wild) (HYPH -) (NN type)) (JJ congenic) (NN line)) (VP (VBD expressed) (NP (JJ striking) (JJ anti-nuclear) (NN autoimmunity))))))) (. .)) )
( (S (PP-MNR (IN By) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (DT this) (NML (NN Chromosome) (CD 1)) (JJ congenic) (NN strain)) (PP (IN with) (NP (NP (VBN matched) (JJ congenic) (NNS mice)) (VP (VBG lacking) (NP (DT the) (NN Apcs) (NN gene)))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NML (NN serum) (NN amyloid) (NN P) (NN component)) (NN deficiency)) (VP (VP (VBZ influences) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN glomerulonephritis))))) (, ,) (CC but) (VP (VBZ is) (RB not) (NP-PRD (DT the) (JJ prime) (NN mover)) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ anti-nuclear) (NN autoimmunity))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ contrary) (PP (IN to) (NP (NP (PRP$ our) (JJ own) (JJ original) (NN interpretation)) (PP (IN of) (NP (PRP$ our) (NNS data)))))))) (CIT (-LRB- -LRB-) (NNP Bickerstaff) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ same) (NN consideration)) (VP (VBZ applies) (PP (IN to) (NP (NP (NP (JJ other) (NNS genes)) (VP (VBN located) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (JJ same) (NML (NN Chromosome) (CD 1)) (NN region))))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN SLE))))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VP (VP (VBN inactivated) (NP-3 (-NONE- *)) (PP (IN by) (NP-LGS (NN gene) (HYPH -) (VBG targeting))) (PP-LOC (IN in) (NP (CD 129) (JJ embryonic) (NN stem) (NNS cells)))) (CC and) (VP (ADVP-TMP (RB then)) (VBD backcrossed) (NP-3 (-NONE- *)) (PP (IN onto) (NP (DT a) (JJ pure) (JJ genetic) (NN background))))) (ADVP-TMP-2 (-NONE- *T*)) (CIT (-LRB- -LRB-) (NNP Bolland) (CC and) (NNP Ravetch) (CD 2000) (: ;) (NNP Miwa) (FW et) (FW al.) (CD 2002) (: ;) (NNP Wu) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))))))))))))) (. .)) )
( (S (PP (IN For) (NP (DT each))) (, ,) (NP-SBJ-1 (EX there)) (VP (VBZ has) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT a) (NN question)) (PP (IN as) (PP (IN to) (SBAR-NOM (IN whether) (S (NP-SBJ (DT the) (JJ anti-nuclear) (NN autoimmunity)) (VP (VBZ is) (PP-PRD (IN due) (PP (PP (IN to) (NP (DT the) (ADJP (NN gene) (HYPH -) (VBN targeted)) (NN mutant) (NN gene))) (CC or) (PP (IN to) (NP (NP (DT the) (JJ normal) (CD 129) (NNS genes)) (VP (VBN expressed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ same) (NN region)) (PP (IN as) (NP (DT the) (VBN targeted) (NN gene)))))))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN influence)) (PP (IN of) (NP (NN background) (NNS genes))) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ spontaneous) (JJ autoimmune) (NN disease)))))) (VP (VBZ is) (ADJP-PRD (RB well) (VBN known)) (, ,) (PP (ADVP (RB especially)) (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (DT the) (NML (NN lpr) (CC and) (NN Yaa)) (NML (NN disease) (HYPH -) (NN susceptibility)) (NNS genes)))))) (. .)) )
( (S (PP-LOC (IN In) (NP (NML (NN MRL) (HYPH /) (NN Mp)) (NNS mice))) (, ,) (NP-SBJ (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NN lpr) (NN gene)))) (VP (VBZ accelerates) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NP (NML (NML (JJ high) (NN level)) (CC and) (NML (NN broad) (HYPH -) (NN spectrum))) (NN auto-Ab) (NN production)) (CC and) (NP (JJ lethal) (NN glomerulonephritis))) (, ,) (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (JJ marked) (JJ lymphoproliferative) (NN disease))))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN homozygosity)) (PP (IN of) (NP (DT the) (NN lpr) (NN gene))) (PP (IN in) (NP (NP (JJ other) (NNS strains)) (PP (JJ such) (IN as) (NP (NP (NN C57BL) (HYPH /) (CD 6)) (, ,) (NP (NN AKR)) (, ,) (NP (NN LG) (HYPH /) (NN J)) (, ,) (CC and) (NP (NN C3H))))))) (VP (VBZ leads) (ADVP (RB only)) (PP (IN to) (NP (NN auto-Ab) (NN production))) (CIT (-LRB- -LRB-) (NNP Izui) (FW et) (FW al.) (CD 1984) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ (NP (DT the) (ADJP (NP (NN Y) (HYPH -) (NN chromosome)) (HYPH -) (VBN linked)) (NN Yaa) (NN gene)) (PP-LOC (IN in) (NP (NML (NML (NN BXSB)) (CC and) (NML (NN MRL) (HYPH /) (NN Mp))) (NNS males)))) (VP (VBZ enhances) (NP (NP (DT the) (JJ rapid) (NN development)) (PP (IN of) (NP (NNS auto-Abs) (CC and) (NN glomerulonephritis)))) (CIT (-LRB- -LRB-) (NNP Izui) (FW et) (FW al.) (CD 1988) (: ;) (NNP Merino) (FW et) (FW al.) (CD 1989) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP-LOC (IN in) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN background))) (, ,) (NP-SBJ (DT the) (NN Yaa) (NN gene)) (VP (VBZ does) (RB not) (VP (VB lead) (PP (IN to) (NP (DT an) (JJ autoimmune) (NN phenotype))) (CIT (-LRB- -LRB-) (NNP Izui) (FW et) (FW al.) (CD 1988) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Not) (RB surprisingly)) (, ,) (NP-SBJ-1 (NP (JJ important) (NNS effects)) (PP (IN of) (NP (DT the) (JJ genetic) (NN background))) (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN autoimmunity)))))) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice))) (CIT (-LRB- -LRB-) (NNP Bolland) (CC and) (NNP Ravetch) (CD 2000) (: ;) (NNP Santiago) (HYPH -) (NNP Raber) (FW et) (FW al.) (CD 2001) (: ;) (NNP Mitchell) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN SLE)) (VP (VBZ exists) (PP (IN as) (NP (NP (DT a) (NML (JJ complex) (HYPH -) (NN trait)) (NN disorder)) (SBAR (WHPP-2 (IN in) (WHNP (WDT which))) (S (NP-SBJ-1 (NP (JJ specific) (NNS combinations)) (PP (IN of) (NP (NN susceptibility) (NNS alleles)))) (VP (VBP are) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (JJ full) (NN phenotype))))) (PP-2 (-NONE- *T*))))))))) (. .)) )
( (S (PP (IN Through) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN microsatellite) (NN marker) (NNS maps))))) (, ,) (NP-SBJ-1 (NP (DT the) (NN identification)) (PP (IN of) (NP (JJ murine) (NML (NN SLE) (NN susceptibility)) (NNS intervals))) (PP-LOC (IN in) (NP (JJ experimental) (NNS crosses)))) (VP (VBZ has) (VP (VBN been) (VP (VBN made) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ possible)))))) (. .)) )
( (S (NP-SBJ (DT These) (NN mapping) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN disease) (NN expression)) (PP (IN in) (NP (NP (NN relation)) (PP (IN to) (NP (NP (DT the) (NN inheritance)) (PP (IN of) (NP (DT the) (JJ different) (NNS alleles)))))))) (VP (VBD followed) (NP (NP (DT a) (NN threshold) (NN liability) (NN pattern)) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ (DT a) (JJ positive) (NN phenotype)) (VP (VBD depended) (PP (IN upon) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ multiple) (JJ discrete) (NN susceptibility) (NNS loci))))) (PP (IN with) (S-NOM (NP-SBJ (DT no) (JJ single) (NN locus)) (VP (VBG being) (NP-PRD (DT a) (JJ prerequisite) (NN factor))))) (PP-1 (-NONE- *T*))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN employed) (NP (DT the) (JJ same) (NN approach)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB analyse) (NP (NP (DT the) (JJ genetic) (NN basis)) (PP (IN of) (NP (NN disease) (NN inheritance))) (PP (IN in) (NP (NP (DT the) (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN hybrid) (NN strain)) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (JJ genetic) (NN background)) (PP-LOC (IN in) (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS mice)))))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (JJ spontaneous) (NN autoimmunity)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN documented) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT either)) (PP (IN of) (NP (DT the) (JJ pure) (NML (NML (CD 129)) (CC or) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS strains)))))))))) (, ,) (NP-SBJ-2 (DT a) (JJ spontaneous) (ADJP (NN lupus) (HYPH -) (JJ like)) (NN phenotype)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN hybrid) (NNS strains))) (CIT (-LRB- -LRB-) (NNP Obata) (FW et) (FW al.) (CD 1979) (: ;) (NNP Botto) (FW et) (FW al.) (CD 1998) (: ;) (NNP Bickerstaff) (FW et) (FW al.) (CD 1999) (: ;) (NNP Santiago) (HYPH -) (NNP Raber) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN predisposition)) (PP-LOC (IN in) (NP (DT these) (JJ hybrid) (NNS mice)))) (VP (MD may) (VP (VB arise) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (JJ specific) (NNS combinations)) (PP (IN of) (NP (NP (NNS alleles)) (VP (VBN inherited) (NP (-NONE- *)) (PP (IN from) (NP (CC both) (DT the) (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (JJ parental) (NNS strains))))))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBD was) (VP (VBN confirmed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN mapping) (NN study)) (VP (VBN reported) (NP (-NONE- *)) (ADVP (RB here))))))) (. .)) )
( (S (S (NP-SBJ (PRP We)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (JJ multiple) (JJ genetic) (NNS loci)) (VP (VBG contributing) (PP (IN to) (NP (DT the) (NN disease)))))))))) (CC and) (S (NP-SBJ-1 (DT these)) (VP (VBP are) (VP (VBN derived) (NP-1 (-NONE- *)) (PP (IN from) (NP (NML (CC both) (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (ADJP (CD 129) (HYPH -) (VBN derived)) (NN segment)) (PP (IN of) (NP (NN Chromosome) (CD 1)))) (VP (VBD was) (ADJP-PRD (RB strongly) (VBN linked) (PP (IN to) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NNS auto-Abs)))))))))) (. .)) )
( (S (S (NP-SBJ (DT This) (NN region)) (VP (VBZ is) (ADVP (RB probably)) (ADJP-PRD (JJ capable) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG causing) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NP (DT a) (JJ humoral) (JJ autoimmune) (NN response)) (PP (IN to) (NP (JJ nuclear) (NNS antigens)))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ (DT this) (NN response)) (VP (VBZ does) (RB not) (VP (VB occur) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NML (NN C57BL) (HYPH /) (CD 6)) (NNS genes)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN support)) (PP (IN of) (NP (DT this))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD identified) (NP (NP (NP (DT a) (NML (NN C57BL) (HYPH /) (CD 6)) (NN segment)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 3)))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (CD 129) (NNS genes)) (PP (IN on) (NP (NN Chromosome) (CD 1))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB mediate) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN tolerance))))))))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NML (NN SLE) (HYPH -) (NN susceptibility)) (NN region)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 3)))) (VP (VBZ is) (ADJP-PRD (JJ novel))))) (, ,) (NP-SBJ-1 (NP (ADJP (NN disease) (HYPH -) (VBG modifying)) (NNS alleles)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NML (NML (NN C57BL) (HYPH /) (CD 10)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS strains))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NP (DT a) (NN portion)) (PP (IN of) (NP (NN Chromosome) (CD 3)))) (ADJP (JJ close) (PP (IN to) (NP (NP (DT the) (NN region)) (VP (VBN identified) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT this) (NN study))))))))) (CIT (-LRB- -LRB-) (NNP Morel) (FW et) (FW al.) (CD 1999) (: ;) (NNP Haywood) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-1 (NP (NP (DT the) (NN region)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 7)))) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN lupus) (NN nephritis))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (JJ same) (NN trait))) (PP-LOC (IN in) (NP (NP (JJ other) (JJ murine) (NNS models)) (PP (IN of) (NP (NN SLE))))) (CIT (-LRB- -LRB-) (NNP Santiago) (FW et) (FW al.) (CD 1998) (: ;) (NNP Morel) (FW et) (FW al.) (CD 1999) (: ;) (NNP Xie) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (VBN shared) (NN susceptibility) (NNS loci))))))))) (. .)) )
( (S (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN Taken) (NP-1 (-NONE- *)) (ADVP (RB together)))) (NP-SBJ (PRP$ our) (NNS results)) (VP (VBP suggest) (NP (NP (DT a) (JJ complex) (JJ genetic) (NN contribution)) (PP (IN from) (NP (NP (DT the) (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (JJ hybrid) (NN background) (NN genome)) (, ,) (PP (IN with) (NP (NP (DT both) (ADJP (VBG enhancing) (CONJP (RB as) (RB well) (IN as)) (JJ inhibitory)) (NNS loci)) (PP (IN from) (NP (DT the) (CD 129) (NN mouse))))) (, ,) (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (NP (NNS genes)) (VP (VBG promoting) (NP (NN autoimmunity)) (PP (IN from) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NNS mice)))))))))))) (. .)) )
( (S (NP-SBJ-2 (NP (NP (DT The) (NN impact)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (DT these) (VBG interacting) (NNS loci)) (VP (MD may) (VP (VB have) (NP-1 (-NONE- *T*))))))) (PP (IN on) (NP (NP (DT the) (ADJP (NN lupus) (HYPH -) (JJ like)) (NN disease)) (ADJP (JJ present) (PP-LOC (IN in) (NP (JJ several) (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS animals))))))) (VP (VBD was) (ADVP (RB further)) (VP (VBN assessed) (NP-2 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (PP (IN with) (NP (ADJP (NP (NN Chromosome) (CD 1)) (RB genetically) (VBN matched)) (NNS controls)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NN SLE) (NN susceptibility))))) (, ,) (NP-SBJ (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (ADVP (RBS most) (RB consistently)) (VBN mapped)) (JJ non-MHC) (NNS regions)) (PP (IN of) (NP (DT the) (NN mouse) (NN genome)))))) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ telomeric) (NML (NN Chromosome) (CD 1)) (NN segment)) (, ,) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-1 (NP (JJ several) (NN disease) (NNS loci)) (, ,) (VP (VBN designated) (NP-2 (-NONE- *)) (S-CLR (NP-SBJ-2 (-NONE- *PRO*)) (NP-PRD (NP (NN Sle1) (CIT (-LRB- -LRB-) (NNP Morel) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (, ,) (NP (NN Nba2) (CIT (-LRB- -LRB-) (NNP Drake) (FW et) (FW al.) (CD 1995) (: ;) (NNP Rozzo) (FW et) (FW al.) (CD 1996) (: ;) (NNP Vyse) (FW et) (FW al.) (CD 1997) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN Bxs3) (CIT (-LRB- -LRB-) (NNP Hogarth) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))))))) (, ,) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NN lupus) (HYPH -) (JJ prone)) (NNS strains))) (ADVP-LOC-3 (-NONE- *T*))))))))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (NP (DT this) (NN region)) (PP (IN of) (NP (NN mouse) (NN Chromosome) (CD 1)))) (VP (VBZ is) (ADJP-PRD (JJ orthologous) (PP (IN to) (NP (NP (NP (DT a) (NN region)) (PP (IN on) (NP (JJ human) (NN Chromosome) (NML (NML (NN 1q22)) (PP (SYM –) (NP (NN 1q25))))))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ human) (NN SLE))) (CIT (-LRB- -LRB-) (NNP Moser) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN Apcs) (NN gene)) (VP (VBZ is) (NP-PRD (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NN candidate) (NNS genes)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB lie) (PP-LOC (IN within) (NP (DT this) (NN region))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ human) (NML (NN serum) (NN amyloid) (NN P)) (NN component)) (VP (VBZ binds) (ADVP (RB avidly)) (PP (PP (IN to) (NP (NP (NP (NN DNA)) (, ,) (NP (NN chromatin)) (, ,) (CC and) (NP (JJ apoptotic) (NNS cells))) (PP-LOC (IN in) (NP (JJ physiological) (NNS conditions))) (ADVP-LOC (FW in) (FW vitro)) (CIT (-LRB- -LRB-) (NNP Pepys) (CD 1974) (: ;) (NNP Pepys) (CC and) (NNP Butler) (CD 1987) (: ;) (NNP Butler) (FW et) (FW al.) (CD 1990) (-RRB- -RRB-)))) (CONJP (CC and) (RB also)) (PP (IN to) (NP (NP (NP (VBN exposed) (NN chromatin)) (CC and) (NP (JJ apoptotic) (NNS cells))) (ADVP-LOC (FW in) (FW vivo)) (CIT (-LRB- -LRB-) (NNP Hintner) (FW et) (FW al.) (CD 1988) (: ;) (NNP Breathnach) (FW et) (FW al.) (CD 1989) (: ;) (NNP Familian) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN reported) (SBAR (IN that) (S (-LRB- -LRB-) (NP-SBJ (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (ADVP (RB spontaneously)) (VP (VP (VBP produce) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NNS ANAs))))) (CC and) (VP (VB develop) (NP (JJ significant) (NML (JJ immune) (NN complex)) (NN glomerulonephritis))) (CIT (-LRB- -LRB-) (NNP Bickerstaff) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-))))))) (. .)) )
( (S (PP (IN On) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT these) (NNS observations))))) (, ,) (NP-SBJ-1 (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBD was) (VP (VBN postulated) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ (NN Apcs)) (, ,) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG altering) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN chromatin))))))) (, ,) (VP (VBZ contributes) (PP (IN to) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN SLE)))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP-LOC (IN in) (NP (DT this) (NN study))) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-1 (RB only) (NML (NML (NN ANA)) (CC and) (NML (JJ anti-chromatin) (NN Ab))) (NNS levels)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT the) (-LRB- -LRB-) (NML (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)))))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (JJ possible) (NN explanation)) (PP (IN for) (NP (DT this) (NN discrepancy)))) (VP (MD may) (VP (VB lie) (PP (IN in) (NP (DT the) (NN fact) (SBAR (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (VP (VBN analysed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (JJ original) (NN study))))) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NNS founders))))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (DT this)) (VP (MD may) (VP (VB have) (VP (VBN caused) (NP (NP (DT a) (JJ nonrandom) (NN inheritance)) (PP (IN of) (NP (DT the) (NNS loci))) (PP (IN from) (NP (DT the) (JJ parental) (NNS strains)))))))))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (DT the) (NML (JJ whole) (HYPH -) (NN genome)) (NN analysis)) (VP (VBD identified) (NP (NP (DT the) (CD 129) (NN region)) (VP (VBG surrounding) (NP (DT the) (NN Apcs) (NN gene)))) (PP (IN as) (NP (NP (DT the) (JJ main) (NN locus)) (VP (VBG contributing) (PP (IN to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NN ANA)) (CC and) (NP (JJ anti-chromatin) (NN Ab)))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (DT this))))) (, ,) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ (PRP we)) (VP (VBD carried) (PRT (RP out)) (NP (NP (DT a) (JJ selective) (NN comparison)) (PP (IN between) (NP (NP (DT the) (-LRB- -LRB-) (NML (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (CC and) (NP (NML (NN Chromosome) (CD 1)) (ADJP (RB genetically) (VBN matched)) (NNS controls))))) (ADVP-TMP-1 (-NONE- *T*))))) (, ,) (NP-SBJ-2 (PRP we)) (VP (VBD failed) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB detect) (NP (NP (DT any) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (DT these) (CD two) (NNS auto-Abs)))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS findings)) (, ,) (S-ADV (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN taken) (NP-2 (-NONE- *)) (ADVP (RB together)))) (, ,) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NN phenotype)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NN Apcs) (NN deficiency))))) (VP (VBD was) (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (JJ unaltered) (CD 129) (NNS genes)) (PP (IN from) (NP (NP (DT the) (JJ telomeric) (NN region)) (PP (IN of) (NP (NN Chromosome) (CD 1)))))) (VP (VBG operating) (PP-LOC (IN in) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (JJ genomic) (NN background))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Strong) (JJ supportive) (NN evidence)) (PP (IN for) (NP (DT this)))) (VP (VBD was) (VP (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NNS mice)))) (ADJP (JJ congenic) (PP (IN for) (NP (DT this) (CD 129) (NN region)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NML (NN generation) (CC and) (NN analysis))) (PP (IN of) (NP (JJ congenic) (NNS strains)))) (VP (VBP have) (ADVP (RB successfully)) (VP (VBN been) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB dissect) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (JJ individual) (NN susceptibility) (NNS alleles))) (PP (IN to) (NP (NP (DT a) (JJ multigenic) (NN trait)) (PP (JJ such) (IN as) (NP (NN SLE)))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD adopted) (NP (DT the) (JJ same) (NN strategy)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ relative) (NN contribution)) (PP (IN of) (NP (NP (DT the) (CD 129) (NML (NN Chromosome) (CD 1)) (NN segment)) (CC and) (NP (DT the) (NN Apcs) (NN gene)))) (PP (IN to) (NP (DT each) (NN disease) (NN trait)))))))) (. .)) )
( (S (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (DT this) (NN approach)))) (, ,) (NP-SBJ (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-3 (NP (DT the) (CD 129) (NN interval)) (PP-LOC (IN on) (NP (JJ distal) (NN Chromosome) (CD 1)))) (, ,) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN transferred) (NP-2 (-NONE- *)) (PP (IN onto) (NP (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN genome)) (, ,) (NP (NP (DT a) (NN combination)) (VP (ADVP-TMP (RB commonly)) (VBN created) (NP (-NONE- *)) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG backcrossing) (PP (IN onto) (NP (NN C57BL) (HYPH /) (CD 6))) (NP (NP (DT a) (VBN mutated) (NN gene)) (VP (VBN located) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT that) (JJ chromosomal) (NN region)))))))))))) (ADVP-TMP-1 (-NONE- *T*))))) (, ,) (VP (VBD was) (ADJP-PRD (JJ sufficient) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB mediate) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NNS auto-Abs)))))))))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN context))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (PP-PRD (IN of) (NP (NN note))) (SBAR-2 (IN that) (S (NP-SBJ-1 (NP (JJ several) (NNS strains)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (VBN targeted) (NNS mutations)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN encoded) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT this) (NN region))))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB express) (NP (DT a) (ADJP (NN lupus) (HYPH -) (JJ like)) (NN illness))))) (, ,) (PP (VBG including) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NP (NN FcγRIIB) (CIT (-LRB- -LRB-) (NNP Bolland) (CC and) (NNP Ravetch) (CD 2000) (-RRB- -RRB-))) (, ,) (NP (NP (NN complement) (NNS receptors)) (-LRB- -LRB-) (NP (NN CR1) (HYPH /) (CD 2)) (-RRB- -RRB-) (CIT (-LRB- -LRB-) (NNP Prodeus) (FW et) (FW al.) (CD 1998) (: ;) (NNP Wu) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (ADJP (NN decay) (HYPH -) (VBG accelerating)) (NN factor)) (-LRB- -LRB-) (NP (NN CD55)) (-RRB- -RRB-) (CIT (-LRB- -LRB-) (NNP Miwa) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))))))))))))) (. .)) )
( (S (PP (IN In) (NP (DT each) (NN case))) (, ,) (NP-SBJ-1 (DT the) (JJ autoimmune) (NN phenotype)) (VP (VBD was) (VP (VBN described) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS mice)) (SBAR (WHPP-3 (IN in) (WHNP (WDT which))) (S (NP-SBJ-2 (DT the) (JJ null) (NN mutation)) (VP (VBD was) (VP (VP (VP (VBN generated) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (CD 129) (JJ embryonic) (NN stem) (NNS cells)))) (CC and) (VP (ADVP-TMP (RB then)) (VBD backcrossed) (NP-2 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6))) (CC or) (NP (DT another) (JJ genetic) (NN background)))))) (PP-LOC-3 (-NONE- *T*)))))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (PP (IN in) (NP (NP (NN view)) (PP (IN of) (NP (PRP$ our) (NNS findings))))) (, ,) (NP-SBJ (PRP one)) (VP (MD may) (VP (VB postulate) (SBAR (IN that) (S (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (NP (DT these) (JJ murine) (NNS models)) (PP (IN of) (NP (NN SLE))))))) (, ,) (NP-SBJ (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT the) (VBN targeted) (JJ null) (NN gene)))) (VP (VBD were) (ADJP-PRD (JJ irrelevant))))))) (. .)) )
( (S (NP-SBJ (JJ Similar) (NNS conclusions)) (VP (MD may) (VP (VB apply) (PP (IN to) (NP (NP (JJ other) (ADJP (NN gene) (HYPH -) (VBN targeted)) (NNS animals)) (VP (VBG carrying) (NP (NP (NNS mutations)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN mapped) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (ADJP (CD 129) (HYPH -) (VBN derived)) (NN susceptibility) (NN allele))) (PP-LOC (IN on) (NP (NN Chromosome) (CD 7)))))))))) (CIT (-LRB- -LRB-) (NNP O'Keefe) (FW et) (FW al.) (CD 1996) (, ,) (CD 1999) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN expression)) (PP (IN of) (NP (JJ anti-nuclear) (NN autoimmunity)))) (VP (VBD was) (ADJP-PRD (JJ identical)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (DT the) (JJ congenic) (NML-1 (-NONE- *RNR*))) (PP (IN with) (NP (DT the) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NML-1 (-NONE- *RNR*)))) (NML-1 (NNS mice))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ only) (NN difference)) (PP (IN in) (NP (NN phenotype))) (PP (IN between) (NP (DT these) (NNS mice)))) (VP (VBD was) (PP-PRD (IN in) (NP (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN glomerulonephritis)))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (ADJP-PRD (RBR more) (JJ pronounced)) (PP-LOC (IN in) (NP (DT the) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice))) (PP (VBN compared) (PP (IN with) (NP (DT the) (JJ congenic) (NNS mice)))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (DT these) (NNS findings)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-2 (NN Apcs)) (VP (VBZ is) (RB not) (VP (VBN implicated) (NP-2 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN processing)) (PP (IN of) (NP (NNS autoantigens))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (PRP it)) (VP (VBD had) (ADVP-TMP (RB previously)) (VP (VBN been) (VP (VBN suggested) (NP-1 (-NONE- *)))))))))))))) (, ,) (NP-SBJ (PRP they)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NN Apcs)) (VP (MD might) (ADVP (RB still)) (VP (VB play) (NP (DT an) (JJ important) (JJ protective) (NN role)) (PP (IN in) (NP (NN lupus) (NN nephritis)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN support)) (PP (IN of) (NP (DT this))))) (, ,) (NP-SBJ-1 (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (JJ human) (ADJP (NN C) (HYPH -) (JJ reactive)) (NN protein)) (, ,) (NP (NP (DT an) (NML (JJ acute) (HYPH -) (NN phase)) (NN protein)) (ADJP (RB closely) (JJ related) (PP (IN to) (NP (NN Apcs)))))))) (, ,) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB delay) (NP (NP (DT the) (NML (NN onset) (CC and) (NN severity))) (PP (IN of) (NP (NN lupus) (NN nephritis)))) (PP-LOC (IN in) (NP (DT the) (NML (NN NZB) (HYPH /) (NN W)) (NN strain))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG preventing) (NP (NP (DT the) (NN deposition)) (PP (IN of) (NP (JJ immune) (NNS complexes)))) (PP-LOC (IN in) (NP (DT the) (JJ renal) (NN cortex)))))) (CIT (-LRB- -LRB-) (NNP Szalai) (FW et) (FW al.) (CD 2003) (-RRB- -RRB-)))))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (DT this))))) (, ,) (NP-SBJ-1 (NP (DT a) (NN polymorphism)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NP (VBN reduced) (JJ basal) (NN level)) (PP (IN of) (NP (ADJP (NN C) (HYPH -) (JJ reactive)) (NN protein))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN SLE))) (PP-LOC (IN in) (NP (NNS humans))) (CIT (-LRB- -LRB-) (NNP Russell) (FW et) (FW al.) (CD 2004) (-RRB- -RRB-))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (NP (DT the) (JJ congenic) (NNS mice)) (CC and) (NP (DT the) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice))) (VP (VBN carried) (NP (ADJP (JJ similar) (CONJP (CC but) (RB not)) (JJ identical)) (CD 129) (NNS regions)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 1)))))) (, ,) (NP-SBJ (NP (DT an) (JJ alternative) (NN explanation)) (PP (IN for) (NP (PRP$ our) (NNS findings)))) (VP (MD may) (ADVP (RB still)) (VP (VB lay) (PP (IN in) (NP (NP (DT the) (ADJP (JJ numerous) (CC and) (JJ complex)) (ADJP (JJ synergistic) (CC and) (JJ counteractive)) (NNS interactions)) (PP (IN between) (NP (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS genes)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NP (NN self) (HYPH -) (NN tolerance)) (CC and) (NP (NN end) (NN organ) (NN damage))))))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (SBAR-ADV (IN whilst) (S (NP-SBJ (NP (DT the) (NN lack)) (PP (IN of) (NP (NN lupus) (NN nephritis))) (PP-LOC (IN in) (NP (DT the) (JJ congenic) (NNS mice)))) (VP (VBZ is) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (JJ multiple) (NN susceptibility) (NNS genes))) (PP (IN for) (NP (NP (DT the) (JJ full) (NN expression)) (PP (IN of) (NP (NN lupus))))))))))) (, ,) (NP-SBJ-1 (JJ further) (NNS studies)) (VP (MD will) (VP (VB be) (VP (VBN required) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (ADVP (RB fully)) (VP (VB elucidate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN Apcs))) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (JJ renal) (NN damage)))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (PRP$ our) (NNS findings)) (VP (VP (VBP demonstrate) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NP (JJ epistatic) (NNS interactions)) (PP (IN between) (NP (NML (CD 129) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS genomes))))) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN SLE))))))) (CC and) (VP (VBP illustrate) (SBAR (WHADVP-2 (WRB how)) (S (NP-SBJ (DT these) (NML (NN background) (NN gene)) (NNS effects)) (VP (MD may) (VP (VB lead) (PP (IN to) (NP (JJ incorrect) (NNS interpretations))) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG analysing) (NP (NP (DT the) (JJ autoimmune) (NN phenotype)) (PP (IN of) (NP (JJ specific) (JJ genetic) (NNS disruptions)))) (ADVP-TMP-1 (-NONE- *T*))))) (ADVP-MNR-2 (-NONE- *T*)))))))) (. .)) )
( (HEADING (NP (NNS Materials) (CC and) (NNS Methods))) )
( (HEADING (NP (NNS Mice) (. .))) )
( (S (NP-SBJ (PDT All) (DT the) (NNS mice)) (VP (VBD were) (NP-PRD (NNS females))) (. .)) )
( (S (NP-SBJ-1 (NML (JJ Wild) (HYPH -) (NN type)) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (CC and) (NML (NML (NN 129) (HYPH /) (NN Sv)) (-LRB- -LRB-) (NML (NML (NN 129S6)) (, ,) (PP (VBG according) (PP (IN to) (NP (DT the) (VBN revised) (NN nomenclature))))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN bred) (CC and) (VBN maintained) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN animal) (NN care)) (NN facility))) (PP-LOC (IN at) (NP (NP (NNP Imperial) (NNP College)) (, ,) (NP-LOC (NNP London)) (, ,) (NP-LOC (NNP United) (NNP Kingdom)))))) (. .)) )
( (S (S (NP-SBJ-1=2 (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F1) (NNS mice)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP=3 (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG intercrossing) (NP (DT the) (CD two) (NML (JJ wild) (HYPH -) (NN type)) (NNS strains)))))))) (CC and) (S (NP-SBJ=2 (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2) (NNS mice)) (PP=3 (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG interbreeding) (NP (DT the) (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F1) (NNS mice)))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN reported) (NP-3 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP Botto) (FW et) (FW al.) (CD 1997) (-RRB- -RRB-)))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (NML (NML (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (VP (VBD were) (VP (VBN generated) (NP-2 (-NONE- *)) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG intercrossing) (NP (NML (NNP Apcs) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (PP (IN on) (NP (DT the) (CD 129) (JJ genetic) (NN background))) (PP (IN with) (NP (NP (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NNS animals)) (VP (VBN backcrossed) (NP (-NONE- *)) (PP (IN onto) (NP (NN C57BL) (HYPH /) (CD 6))) (PP-TMP (IN for) (NP (CD ten) (NNS generations)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 141) (NML (-LRB- -LRB-) (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (NML-2 (-NONE- *RNR*)))) (CC and) (NP (CD 158) (-LRB- -LRB-) (NML (NML (NML (CD 129) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NML-2 (-NONE- *RNR*))) (NML-2 (JJ female) (NNS mice))))) (VP (VBD were) (VP (VBN produced) (CC and) (VBN monitored) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 1) (NN y))))) (. .)) )
( (S (NP-SBJ-1 (NML (JJ Wild) (HYPH -) (NN type)) (JJ congenic) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (CD 129) (PRN (-LRB- -LRB-) (NP (NP (NN D1Mit105)) (PP (SYM –) (NP (CD 223)))) (-RRB- -RRB-)))) (NNS mice)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG backcrossing) (NP (NP (DT the) (CD 129) (NN interval)) (PP (IN between) (NP (NNS microsatellites) (NML (NN D1Mit105) (CC and) (NN D1Mit223)) (PRN (-LRB- -LRB-) (NP (NP (CD 80) (NN cM)) (PP (IN to) (NP (CD 106) (NN cM)))) (-RRB- -RRB-))))) (PP (IN onto) (NP (DT the) (NML (NN C57BL) (HYPH /) (CD 6)) (NN strain)))))))) (. .)) )
( (S (NP-SBJ-1 (VBN Inherited) (CD 129) (NNS regions)) (VP (VBD were) (VP (VBN mapped) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NN microsatellite) (NNS markers)) (ADJP (JJ polymorphic) (PP (IN between) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (ADVP (RB below)))) (-RRB- -RRB-))))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NP (CD seven) (NNS generations)) (PP (IN of) (NP (VBG backcrossing))))) (, ,) (NP-SBJ-1 (NNS siblings)) (VP (VBD were) (VP (VBN intercrossed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (NP (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (CD 129) (PRN (-LRB- -LRB-) (NP (NP (NN D1Mit105)) (PP (SYM –) (NP (CD 223)))) (-RRB- -RRB-)))) (JJ congenic) (NNS mice)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (CD 129) (NML (NN Chromosome) (CD 1)) (NN interval)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (JJ Inside) (CD 129) (NNS markers)) (PP-LOC (IN at) (NP (NP (NNS positions) (NML (NML (CD 81.6) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit159)) (-RRB- -RRB-))) (CC and) (NML (CD 105) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit17)) (-RRB- -RRB-))))) (, ,) (ADVP (RB respectively))))) (, ,) (CC and) (NP (NP (DT an) (JJ outside) (NML (NN C57BL) (HYPH /) (CD 6)) (NN marker)) (PP (IN at) (NP (NN position) (NN 74.3cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit159)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (ADVP (RB further)) (VP (VB define) (NP (DT the) (NN interval))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (DT the) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (-LRB- -LRB-) (VP (VBN backcrossed) (NP (-NONE- *)) (PP (IN onto) (NP (NN C57BL) (HYPH /) (CD 6))) (PP-TMP (IN for) (NP (CD ten) (NNS generations)))) (-RRB- -RRB-))) (, ,) (NP-SBJ-1 (NP (DT the) (CD 129) (NN genome)) (PP-LOC (IN around) (NP (DT the) (NN Apcs) (NN locus)))) (VP (VBD was) (VP (VBN mapped) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT a) (NN segment)) (PP (PP (IN from) (NP (CD 87.9) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit15)) (-RRB- -RRB-)))) (PP (IN to) (NP (CD 105) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit17)) (-RRB- -RRB-))))))))) (. .)) )
( (S (S (PP-LOC (IN In) (NP (DT this) (NN analysis))) (, ,) (NP-SBJ=2 (DT the) (JJ inside) (CD 129) (NNS markers)) (VP (VBD were) (PP-LOC-PRD=1 (IN at) (NP (NNS positions) (NML (NML (CD 93) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit36)) (-RRB- -RRB-))) (CC and) (NML (CD 99.7) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit115)) (-RRB- -RRB-)))))))) (CC and) (S (NP-SBJ=2 (DT the) (JJ outside) (NML (NN C57BL) (HYPH /) (CD 6)) (NNS markers)) (PP-LOC-PRD=1 (IN at) (NP (NNS positions) (NML (NML (CD 81.6) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit159)) (-RRB- -RRB-))) (CC and) (NML (CD 106) (NN cM) (PRN (-LRB- -LRB-) (NP (NN D1Mit223)) (-RRB- -RRB-))))))) (. .)) )
( (S (PP (IN Along) (PP (IN with) (NP (NP (CD 28) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (CC and) (NP (CD 30) (NML (NN C57BL) (HYPH /) (CD 6)) (NML (JJ wild) (HYPH -) (NN type)) (NNS animals))))) (, ,) (NP-SBJ-1 (CD 26) (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (CD 129) (PRN (-LRB- -LRB-) (NP (NP (NN D1Mit105)) (PP (SYM –) (NP (CD 223)))) (-RRB- -RRB-)))) (JJ female) (NNS mice) (SYM −) (HYPH /) (SYM −)) (VP (VBD were) (VP (VBN followed) (NP-1 (-NONE- *)) (PP-TMP (IN up) (PP (IN to) (NP (NP (CD 1) (NN y)) (PP (IN of) (NP (NN age)))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Animals)) (VP (VBD were) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (JJ specific) (ADJP (NN pathogen) (HYPH -) (JJ free)) (NNS conditions))))) (. .)) )
( (S (NP-SBJ (DT All) (NN animal) (NNS procedures)) (VP (VBD were) (PP-PRD (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (JJ institutional) (NNS guidelines)))))) (. .)) )
( (HEADING (NP (JJ Serological) (NNS analyses) (. .))) )
( (S (NP-SBJ-1 (NP (NNS Sera)) (, ,) (VP (VBN collected) (NP (-NONE- *)) (PP-TMP (IN at) (NP (NP (NML (CD 6) (CC and) (CD 12)) (NN mo)) (PP (IN of) (NP (NN age))))))) (, ,) (VP (VBD were) (VP (VBN assayed) (NP-1 (-NONE- *)) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS auto-Abs))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (NNS Levels)) (PP (IN of) (NP (NN IgG) (NN ANA)))) (VP (VBD were) (VP (VBN sought) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ indirect) (NN immunofluorescence))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NN Hep) (HYPH -) (CD 2)) (NNS cells))))))) (, ,) (CC and) (S (NP-SBJ-2 (JJ anti-dsDNA) (NNS Abs)) (VP (VBD were) (VP (VBN detected) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ indirect) (NN immunofluorescence)) (PP-LOC (IN on) (NP (NNP Crithidia) (NNP luciliae))))) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-3 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP Mitchell) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-)))))))) (. .)) )
( (S (S (NP-SBJ-1=2 (NN Serum) (NNS samples)) (VP (VBD were) (VP=3 (VBN screened) (NP-1 (-NONE- *)) (PP (IN at) (NP (DT a) (NML (NML (NML (CD 1)) (PP (SYM :) (NP (CD 80))) (PRN (-LRB- -LRB-) (NP (NN ANA)) (-RRB- -RRB-))) (CC or) (NML (NML (CD 1)) (PP (SYM :) (NP (CD 20))) (PRN (-LRB- -LRB-) (NP (JJ anti-dsDNA)) (-RRB- -RRB-)))) (NN dilution)))))) (CC and) (S (NP-SBJ-4=2 (DT the) (JJ positive) (NNS samples)) (VP=3 (VBN titrated) (NP-4 (-NONE- *)) (PP (IN to) (NP (NN endpoint))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Abs)) (PP (IN to) (NP (NN ssDNA) (CC and) (NN anti-chromatin)))) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNP ELISA))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP Mitchell) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))))))) (. .)) )
( (S (S (NP-SBJ-3 (NNS Samples)) (VP (VBD were) (VP (VBN screened) (NP-3 (-NONE- *)) (PP (IN at) (NP (DT a) (NML (NML (CD 1)) (PP (SYM :) (NP (CD 100)))) (NN dilution)))))) (, ,) (CC and) (S (NP-SBJ-1 (DT the) (NNS results)) (VP (VBD were) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NP (JJ arbitrary) (NNP ELISA) (NNS units)) (-LRB- -LRB-) (NP (NNS AEUs)) (-RRB- -RRB-)) (ADJP (JJ relative) (PP (IN to) (NP (NP (NP (DT a) (JJ standard) (JJ positive) (NN sample)) (-LRB- -LRB-) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT an) (NML (NML (NN MRL) (HYPH /) (NN Mp)) (HYPH .) (NML (NN lpr) (HYPH /) (NN lpr))) (NN mouse)))) (-RRB- -RRB-)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD was) (VP (VBN assigned) (NP-2 (-NONE- *)) (NP (NP (DT a) (NN value)) (PP (IN of) (NP (CD 100)))))))))))))))) (. .)) )
( (S (PP (IN For) (NP (JJ interplate) (NN comparison))) (, ,) (NP-SBJ-1 (NP (JJ serial) (NNS dilutions)) (PP (IN of) (NP (DT a) (JJ positive) (NN control) (NN serum) (NN sample)))) (VP (VBD were) (VP (VBN included) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (DT each) (NN plate))))) (. .)) )
( (S (NP-SBJ-1 (NN Apcs) (NNS levels)) (VP (VBD were) (VP (VBN assessed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NNP ELISA))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NML (NN sheep) (JJ anti-mouse) (NN Apcs)) (CC and) (NML (NN rabbit) (JJ anti-mouse) (NN Apcs))) (NNS Abs) (PRN (-LRB- -LRB-) (NP (NP (NNP Calbiochem)) (, ,) (NP-LOC (NNP Nottigham)) (, ,) (NP-LOC (NNP United) (NNP Kingdom))) (-RRB- -RRB-))))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Samples)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP (IN at) (NP (DT a) (NML (NML (CD 1)) (PP (SYM :) (NP (CD 3,000)))) (NN dilution)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (NNS results)) (VP (VBD were) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP (IN in) (NP (NP (NNS milligrams)) (PP (IN per) (NP (NNS liters))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG referring) (PP (IN to) (NP (NP (DT a) (JJ standard) (NN curve)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (DT an) (NML (JJ acute) (HYPH -) (NN phase)) (NN serum)) (PP (IN with) (NP (NP (DT a) (VBN known) (NN concentration)) (PP (IN of) (NP (NN Apcs))))) (PRN (-LRB- -LRB-) (NP (NNP Calbiochem)) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (NN mouse) (NN serum)) (VP (VBD was) (VP (VBN included) (NP-1 (-NONE- *)) (PP (IN as) (NP (DT a) (JJ negative) (NN control))))) (. .)) )
( (HEADING (NP (JJ Histological) (NN analysis) (. .))) )
( (S (S (NP-SBJ-2 (NP (PDT All) (DT the) (NNS mice)) (, ,) (PP (IN except) (NP (NP (DT the) (JJ few)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD died) (PP-TMP (IN before) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN experiment))))))))))) (, ,) (VP (VBD were) (VP (VBN sacrificed) (NP-2 (-NONE- *)) (PP-TMP (IN at) (NP (NP (CD 1) (NN y)) (PP (IN of) (NP (NN age)))))))) (, ,) (CC and) (S (NP-SBJ-3 (NN kidney) (NNS portions)) (VP (VBD were) (VP (VP (VBN fixed) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NNP Bouin) (POS 's)) (NN solution)))) (CC and) (VP (NN paraffin) (VBN embedded) (NP-3 (-NONE- *)))))) (, ,) (CC and) (S (NP-SBJ-4 (NNS sections)) (VP (VBD were) (VP (VBN stained) (NP-4 (-NONE- *)) (PP (IN with) (NP (NP (JJ periodic) (NN acid)) (HYPH –) (NP (NNP Schiff) (NN reagent))))))) (. .)) )
( (FRAG (S (NP-SBJ-1 (JJ Glomerular) (NN histology)) (VP (VBD was) (VP (VBN graded) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (DT a) (JJ blinded) (NN fashion))) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows))))))) (: :) (FRAG (FRAG (NP (NN grade) (CD 0)) (, ,) (ADJP (JJ normal))) (: ;) (FRAG (NP (NN grade) (CD 1)) (, ,) (NP (NP (NN hypercellularity)) (VP (VBG involving) (NP (NP (QP (JJR greater) (IN than) (CD 50)) (NN %)) (PP (IN of) (NP (DT the) (JJ glomerular) (NN tuft)))) (PP-LOC (IN in) (NP (NP (NP (CD 25) (NN %)) (PP-2 (-NONE- *RNR*))) (PP (SYM –) (NP (NP (CD 50) (NN %)) (PP-2 (-NONE- *RNR*)))) (PP-2 (IN of) (NP (NNS glomeruli)))))))) (: ;) (FRAG (NP (NN grade) (CD 2)) (, ,) (NP (NP (NN hypercellularity)) (VP (VBG involving) (NP (NP (QP (JJR greater) (IN than) (CD 50)) (NN %)) (PP (IN of) (NP (NP (DT the) (JJ glomerular) (NN tuft)) (PP-LOC (IN in) (NP (NP (CD 50) (NN %)) (PP (SYM –) (NP (CD 75) (NN %))) (PP (IN of) (NP (NNS glomeruli))))))))))) (: ;) (FRAG (NP (NN grade) (CD 3)) (, ,) (NP (NP (JJ glomerular) (NN hypercellularity)) (PP-LOC (IN in) (NP (NP (QP (JJR greater) (IN than) (CD 75)) (NN %)) (PP (IN of) (NP (NNS glomeruli) (CC or) (NNS crescents))))) (PP (IN in) (NP (NP (QP (JJR greater) (IN than) (CD 25)) (NN %)) (PP (IN of) (NP (NNS glomeruli)))))))) (. .)) )
( (HEADING (NP (JJ Statistical) (NN analysis))) )
( (S (NP-SBJ-1 (JJ Non-parametric) (NNS data)) (VP (VBP are) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN as) (NP (NN median))) (SBAR-ADV (IN with) (S (NP-SBJ (NP (NN range)) (PP (IN of) (NP (NNS values)))) (PP-LOC-PRD (IN in) (NP (NNS parentheses))))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS statistics)) (VP (VBD were) (VP (VBN calculated) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NP (NNP GraphPad) (NNP PrismTM)) (NP-ADV (NN version) (CD 3.0))) (PP (IN for) (NP (NNP Windows))) (PRN (-LRB- -LRB-) (NP (NP (NNP GraphPad) (NNP Software)) (, ,) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Non-parametric) (NNS tests)) (VP (VBD were) (VP (VBN applied) (NP-1 (-NONE- *)) (ADVP (RB throughout)) (, ,) (PP (IN with) (S-NOM (NP-SBJ-2 (NNS differences)) (VP (VBG being) (VP (VBN considered) (S (NP-SBJ-2 (-NONE- *)) (ADJP-PRD (JJ significant) (PP (IN for) (NP (NP (NN p) (NNS values)) (ADJP (SYM <) (NP (CD 0.05))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NNP Mann) (HYPH –) (NNP Whitney)) (NN test)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN for) (NP (NP (NN comparison)) (PP (IN of) (NP (CD two) (NNS groups))))) (, ,) (SBAR-ADV (IN whilst) (S (PP-PRP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (CD three) (NNS groups))))) (NP-SBJ-2 (NP (DT the) (NML (NNP Kruskal) (HYPH –) (NNP Wallis)) (NN test)) (PP (IN with) (NP (NML (NNP Dunn) (POS 's)) (NML (JJ multiple) (NN comparison)) (NN test)))) (VP (VBD was) (VP (VBN used) (NP-2 (-NONE- *)))))))) (. .)) )
( (HEADING (NP (JJ Genotypic) (NN analysis))) )
( (S (NP-SBJ-1 (NN Genotyping)) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN by) (NP (NP (NN PCR)) (PP (IN of) (NP (JJ genomic) (NN DNA))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (CD 143) (JJ polymorphic) (NNS markers) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN list)) (ADJP-PRD (JJ available)) (PP (IN on) (NP (NN request)))) (-RRB- -RRB-))) (VP (VBN distributed) (NP (-NONE- *)) (PP-LOC (IN throughout) (NP (DT all) (CD 19) (NNS autosomes))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS PCRs)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (JJ standard) (NNS reagents)) (VP (VBG containing) (NP (NP (NML (CD 1.5) (NN mM)) (NN MgCl2)) (CC and) (NP (NML (CD 0.4) (NN μM)) (NNS primers))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Microsatellite) (NNS markers)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (NN size) (NNS polymorphisms)) (PP (IN between) (NP (NML (NML (CD 129)) (CC and) (NML (NN C57BL) (HYPH /) (CD 6))) (NNS mice))))))) (. .)) )
( (S (NP-SBJ-1 (NP (RB Only) (NNS primers)) (PP (IN with) (NP (NP (NNS differences)) (ADJP (JJ detectable) (PP-LOC (PP (IN on) (NP (ADJP (NP (NN ethidium) (NN bromide)) (HYPH -) (VBN stained)) (NN agarose) (NNS gels))) (CC or) (PP (IN on) (NP (NML (NN SDS) (HYPH -) (NN polyacrylamide)) (NNS gels)))))))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)))) (. .)) )
( (HEADING (NP (NN Linkage) (NN analysis))) )
( (S (S (NP-SBJ-1 (NP (DT The) (NN QTL) (NN program)) (NP (NNP MAPMANAGER.QTL)) (PRN (-LRB- -LRB-) (NP (NN ftp://mcbio.med.buffalo.edu/pub/MapMgr/)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (CD two) (JJ experimental) (NNS groups)) (VP (VBD were) (VP (VBN examined) (NP-2 (-NONE- *)) (ADVP-MNR (RB independently))))) (. .)) )
( (S (NP-SBJ-1 (NP (RB Only) (NNS data)) (PP (IN from) (NP (NP (NNS mice)) (PP-TMP (IN at) (NP (NP (CD 12) (NN mo)) (PP (IN of) (NP (NN age)))))))) (VP (VBD were) (VP (VBN analysed) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Log) (NNS transformations)) (PP (IN of) (NP (NNS auto-Abs) (NNS levels)))) (VP (VP (VBD resulted) (PP (IN in) (NP (ADJP (RBR more) (VBN normalised)) (NN distribution)))) (CC and) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN QTL) (NN mapping)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN LOD) (NNS thresholds)) (PP (IN for) (NP (ADJP (JJ suggestive) (CC and) (JJ significant)) (NNS linkages)))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (ADJP (NP (NN cohort) (HYPH -) (CC and) (NN trait) (HYPH -)) (JJ specific)) (NN permutation) (NN test) (PRN (-LRB- -LRB-) (NP (CD 1,000) (NNS permutations)) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ average) (NN threshold)) (PP (IN for) (NP (ADJP (ADJP (JJ suggestive)) (, ,) (ADJP (JJ significant)) (, ,) (CC and) (ADJP (RB highly) (JJ significant))) (NNS linkages)))) (VP (VBD were) (NP-PRD (NP (NP (NN LOD)) (ADJP (SYM ≥) (NP (CD 2.1))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM ≤) (NP (QP (CD 7.8) (SYM ×) (CD 10) (SYM −) (CD 3))))) (-RRB- -RRB-))) (, ,) (NP (NP (NN LOD)) (ADJP (SYM ≥) (NP (CD 3.6))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM ≤) (NP (QP (CD 2.4) (SYM ×) (CD 10) (SYM −) (CD 4))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN LOD)) (ADJP (SYM ≥) (NP (CD 5))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM ≤) (NP (QP (CD 1) (SYM ×) (CD 10) (SYM −) (CD 5))))) (-RRB- -RRB-)))) (, ,) (ADVP (RB respectively)) (CIT (-LRB- -LRB-) (NNP Manly) (CC and) (NNP Olson) (CD 1999) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (VBG Supporting) (NN Information))) )
( (HEADING (NP (NN Accession) (NNS Numbers))) )
( (S (NP-SBJ (NP (DT The) (NML (NNP LocusLink) (PRN (-LRB- -LRB-) (NP (NN http://www.ncbi.nlm.nih.gov/LocusLink/)) (-RRB- -RRB-))) (NN ID) (NNS numbers)) (PP (IN for) (NP (NP (DT the) (NML (NML (NNS genes)) (CC and) (NML (NN gene) (NNS products)))) (VP (VBN discussed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT this) (NN paper))))))) (VP (VBP are) (NP-PRD (NP (NN Apcs) (PRN (-LRB- -LRB-) (NP (NNP LocusLink) (NN ID) (CD 20219)) (-RRB- -RRB-))) (, ,) (NP (NN CD35) (HYPH /) (NN CD21) (PRN (-LRB- -LRB-) (NP (NNP LocusLink) (NN ID) (CD 12902)) (-RRB- -RRB-))) (, ,) (NP (NN CD55) (PRN (-LRB- -LRB-) (NP (NNP LocusLink) (NN ID) (CD 13136)) (-RRB- -RRB-))) (, ,) (NP (DT the) (NN FAS) (NN receptor) (NN gene) (PRN (-LRB- -LRB-) (NP (NNP LocusLink) (NN ID) (CD 14102)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN FcγRII) (PRN (-LRB- -LRB-) (NP (NNP LocusLink) (NN ID) (CD 14130)) (-RRB- -RRB-))))) (. .)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBP are) (ADJP-PRD (JJ grateful) (PP=1 (IN to) (NP (NNP M.) (NNP Lewis)))) (PP-PRP=2 (IN for) (NP (NP (DT the) (NN processing)) (PP (IN of) (NP (DT the) (NNS samples))) (PP (IN for) (NP (NN histology)))))) (CC and) (VP (PP=1 (IN to) (NP (NP (NNP F.) (NNP Reid)) (CC and) (NP (NNP D.) (NNP Mitchell)))) (PP-PRP=2 (IN for) (NP (PRP$ their) (NN help))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP thank) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (NN staff)) (PP-LOC (IN in) (NP (DT the) (NN animal) (NN facility)))))) (PP-PRP (IN for) (NP (PRP$ their) (JJ technical) (NN assistance)))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN work)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NNP Wellcome) (NNP Trust) (PRN (-LRB- -LRB-) (NP (NN grant) (NN number) (CD 061438)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NNP JCH)) (VP (VBD was) (NP-PRD (NP (DT a) (NN recipient)) (PP (IN of) (NP (NP (DT a) (NN fellowship)) (PP (IN from) (NP (NP (NP (DT the) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Health)))) (, ,) (NP-LOC (NNP Spain)) (PRN (-LRB- -LRB-) (NP (NN BEFI) (CD 99) (HYPH /) (CD 9212)) (-RRB- -RRB-)))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (NP (NP (NN Ab)) (: -) (NP (NN antibody))) )
( (NP (NP (NN ANA)) (: -) (NP (JJ anti-nuclear) (NN antibody))) )
( (NP (NP (NN AEU)) (: -) (NP (JJ arbitrary) (NNP ELISA) (NN unit))) )
( (NP (NP (NN Apcs) (SYM −) (HYPH /) (SYM −)) (: -) (NP (ADJP (NN Apcs) (HYPH -) (JJ deficient)) (NNS mice))) )
( (NP (NP (NN Apcs)) (: -) (NP (NML (NN serum) (NN amyloid) (NN P) (NN component)) (NN gene))) )
( (NP (NP (NN dsDNA)) (: -) (NP (ADJP (RB double) (HYPH -) (VBN stranded)) (NN DNA))) )
( (NP (NP (NN LOD)) (: -) (NP (NP (NN logarithm)) (PP (IN of) (NP (NNS odds))))) )
( (NP (NP (NN QTL)) (: -) (NP (NML (JJ quantitative) (NN trait)) (NN linkage))) )
( (NP (NP (NN SLE)) (: -) (NP (JJ systemic) (NN lupus) (NN erythematosus))) )
( (NP (NP (NN ssDNA)) (: -) (NP (ADJP (JJ anti-single) (HYPH -) (VBN stranded)) (NN DNA))) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (CAPTION (NP (NP (NN Linkage)) (PP (IN of) (NP (NN Chromosome) (CD 2))) (PP (IN with) (NP (NP (NN ANA)) (CC and) (NP (JJ Anti-Chromatin) (NNS Abs)))) (PP-LOC (IN in) (NP (-LRB- -LRB-) (NML (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS Mice))))) )
( (CAPTION (S (NP-SBJ-1 (DT These) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2) (NNS animals))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Centimorgan) (NNS positions)) (VP (VBD were) (VP (VBN deduced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN interval) (NN mapping))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG anchoring) (NP (NN marker) (NNS locations)) (PP (IN to) (NP (NP (NNS data)) (PP (IN from) (NP (NN http://www.informatics.jax.org))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (JJ Dotted) (NNS lines)) (CC and) (NP (DT the) (JJ dashed) (NN line))) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-2 (IN over) (WHNP (WDT which))) (S (NP-SBJ-1 (NNS linkages)) (VP (VBD were) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ suggestive) (CC or) (JJ significant)) (, ,) (ADVP (RB respectively))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN defined) (NP-3 (-NONE- *)) (PP (IN in) (NP (NNS Materials) (CC and) (NNS Methods)))))) (PP-2 (-NONE- *T*)))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (CAPTION (NP (NP (NN Linkage)) (PP (IN of) (NP (NN Chromosome) (CD 4))) (PP (IN with) (NP (JJ Anti-dsDNA) (NNS Abs))))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (VBN estimated) (NN peak)) (PP-LOC (IN in) (NP (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2) (NNS mice)))) (VP (VBD was) (PP-PRD (IN at) (NP (NN position) (CD 51.3) (NN cM))) (, ,) (SBAR-ADV (IN whilst) (S (PP (IN in) (NP (DT the) (NML (-LRB- -LRB-) (NML (NML (CD 129) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS animals))) (NP-SBJ (PRP it)) (X (VBD was)) (VP (VBD was) (PP-LOC-PRD (IN at) (NP (NN position) (CD 71) (NN cM))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (ADVP (RBS most) (RB likely)) (NP-SBJ (DT these)) (VP (VBD were) (NP-PRD (CD two) (JJ independent) (NNS loci))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Centimorgan) (NNS positions)) (VP (VBD were) (VP (VBN deduced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ interval) (NN mapping))) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG anchoring) (NP (NN marker) (NNS locations)) (PP (IN to) (NP (NP (NNS data)) (PP (IN from) (NP (NN http://www.informatics.jax.org))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Dotted) (NNS lines)) (X (DT the)) (VP (VBP indicate) (NP (NP (NN threshold)) (SBAR (WHPP-2 (IN over) (WHNP (WDT which))) (S (NP-SBJ-1 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ suggestive)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN defined) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (NNS Materials) (CC and) (NNS Methods))))))) (PP-2 (-NONE- *T*)))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (CAPTION (NP (NP (NN Interval) (NN Mapping) (NNS Scans)) (VP (VBG Showing) (NP (NN QTL)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 1))) (PP (IN with) (NP (ADJP (JJ Anti-dsDNA) (CC and) (JJ Anti-ssDNA)) (NNS Abs)))))) )
( (CAPTION (S (NP-SBJ-1 (NN Centimorgan) (NNS positions)) (VP (VBD were) (VP (VBN deduced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ interval) (NN mapping))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG anchoring) (NP (NN marker) (NNS locations)) (PP (IN to) (NP (NP (NNS data)) (PP (IN from) (NP (NN http://www.informatics.jax.org))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ Dotted) (NNS lines)) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-2 (IN over) (WHNP (WDT which))) (S (NP-SBJ-1 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ suggestive))) (PP-2 (-NONE- *T*))))))))) (, ,) (S (NP-SBJ (JJ dashed) (NNS lines)) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-4 (IN over) (WHNP (WDT which))) (S (NP-SBJ-3 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-3 (-NONE- *)) (ADJP-PRD (JJ significant))) (PP-4 (-NONE- *))))))))) (, ,) (CC and) (S (NP-SBJ (ADJP (JJ dotted) (HYPH /) (JJ dashed)) (NNS lines)) (VP (VBP indicate) (NP (ADJP (RB highly) (JJ significant)) (NN linkage)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-5 (-NONE- *PRO*)) (VP (VBN defined) (NP-5 (-NONE- *)) (PP (IN in) (NP (NNS Materials) (CC and) (NNS Methods)))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB See) (NP (NN Table) (CD 3)) (PP-PRP (IN for) (NP (JJ additional) (NNS details)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (CAPTION (S (NP-SBJ (NN Interval) (NN Mapping) (NNS Scans)) (VP (VBG Showing) (NP (NN QTL)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 1))) (PP (IN with) (NP (NP (NN ANA)) (CC and) (NP (NN Anti-Chromatin) (NNS Abs))))))) )
( (CAPTION (S (NP-SBJ-1 (NN Centimorgan) (NNS positions)) (VP (VBD were) (VP (VBN deduced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN interval) (NN mapping))) (, ,) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG anchoring) (NP (NN marker) (NNS locations)) (PP (IN to) (NP (NP (NNS data)) (PP (IN from) (NP (NN http://www.informatics.jax.org))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ Dotted) (NNS lines)) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-2 (IN over) (WHNP (WDT which))) (S (NP-SBJ-1 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ suggestive))) (PP-2 (-NONE- *T*))))))))) (, ,) (CC and) (S (NP-SBJ (JJ dashed) (NNS lines)) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-4 (IN over) (WHNP (WDT which))) (S (NP-SBJ-3 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-3 (-NONE- *)) (ADJP-PRD (JJ significant))) (PP-4 (-NONE- *T*))))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-5 (-NONE- *PRO*)) (VP (VBN defined) (NP-5 (-NONE- *)) (PP-LOC (IN in) (NP (NNS Materials) (CC and) (NNS Methods)))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB See) (NP (NN Table) (CD 3)) (PP (IN for) (NP (JJ additional) (NNS details)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (CAPTION (NP (NN Auto-Ab) (NNS Profiles))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN ANA) (NNS titres)) (PP-LOC (IN in) (NP (NP (DT the) (-LRB- -LRB-) (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6)) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (CC and) (NP (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)))) (PP-TMP (IN at) (NP (NP (CD 1) (NN y)) (PP (IN of) (NP (NN age))))) (. .))) )
( (CAPTION (S (S (S (NP-SBJ=1 (DT A) (JJ small) (NN circle)) (VP (VBZ represents) (NP=2 (CD one) (NN mouse)))) (: ;) (S (NP-SBJ=1 (DT a) (JJ large) (NN circle)) (, ,) (NP=2 (NP (DT a) (JJ variable) (NN number)) (PP (IN of) (NP (NNS animals)))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN indicated) (NP-3 (-NONE- *)) (PP (IN in) (NP (NNS parentheses)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Serum) (NNS samples)) (VP (VBD were) (VP (VBN titrated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN endpoint))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN ANA) (NNS titres)) (PP (IN in) (NP (NP (DT the) (-LRB- -LRB-) (NML (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (CC and) (NP (NP (DT a) (VBN selected) (NN number)) (PP (IN of) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (-LRB- -LRB-) (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (NNS animals)) (VP (VBG carrying) (NP (NP (DT the) (NML (NN Chromosome) (CD 1)) (NN region)) (PP (IN between) (NP (NN D1Mit105) (CC and) (NN D1Mit223) (PRN (-LRB- -LRB-) (NP (QP (CD 80) (SYM –) (CD 106)) (NN cM)) (-RRB- -RRB-)))) (PP (IN of) (NP (CD 129) (NN origin)))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NNS symbols)) (VP (VBP are) (PP-PRD (IN as) (PP (IN in) (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (CC and) (LS D) (-RRB- -RRB-)) (NP (NP (JJ Anti-chromatin) (NN Ab) (NNS levels)) (VP (VBN expressed) (NP (-NONE- *)) (PP (IN in) (NP (NNS AEUs))))) (ADJP (JJ related) (PP (IN to) (NP (NP (DT a) (JJ standard) (JJ positive) (NN sample)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN assigned) (NP-1 (-NONE- *)) (NP (NP (DT a) (NN value)) (PP (IN of) (NP (CD 100) (NN AEU))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NN comparison)) (VP (VBZ is) (PP-PRD (IN between) (NP (NP (DT the) (JJ same) (NNS groups)) (PP (IN of) (NP (NNS mice))) (PP (IN as) (PP (IN in) (NP (-LRB- -LRB-) (NN A) (-RRB- -RRB-) (CC and) (-LRB- -LRB-) (NN B) (-RRB- -RRB-)))))) (, ,) (ADVP (RB respectively))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NNS symbols)) (VP (VBP are) (PP-PRD (IN as) (PP (IN in) (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 7))) )
( (CAPTION (NP (NP (NN Interval) (NN Mapping) (NNS Scans)) (VP (VBG Showing) (NP (NN QTL)) (PP-LOC (IN on) (NP (NN Chromosome) (CD 3))) (PP (IN with) (NP (NML (NN ANA) (, ,) (JJ Anti-Chromatin) (, ,) (CC and) (JJ Anti-ssDNA)) (NNS Abs)))))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB See) (NP (NN Table) (CD 3)) (PP-PRP (IN for) (NP (JJ additional) (NNS details)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Centimorgan) (NNS positions)) (VP (VBD were) (VP (VBN deduced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ interval) (NN mapping))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG anchoring) (NP (NN marker) (NNS locations)) (PP (IN to) (NP (NP (NNS data)) (PP (IN from) (NP (NN http://www.informatics.jax.org))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ Dotted) (NNS lines)) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-2 (IN over) (WHNP (WDT which))) (S (NP-SBJ-1 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ suggestive))) (PP-2 (-NONE- *T*))))))))) (, ,) (S (NP-SBJ (DT the) (JJ dashed) (NN line)) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-4 (IN over) (WHNP (WDT which))) (S (NP-SBJ-3 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-3 (-NONE- *)) (ADJP-PRD (JJ significant))) (PP-4 (-NONE- *))))))))) (, ,) (CC and) (S (NP-SBJ (ADJP (JJ dotted) (HYPH /) (JJ dashed)) (NNS lines)) (VP (VBP indicate) (NP (ADJP (RB highly) (JJ significant)) (NN linkage)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-5 (-NONE- *PRO*)) (VP (VBN defined) (NP-5 (-NONE- *)) (PP (IN in) (NP (NNS Materials) (CC and) (NNS Methods)))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 8))) )
( (CAPTION (NP (NN Auto-Ab) (NNS Profiles))) )
( (CAPTION (NP (-LRB- -LRB-) (LST (LS A)) (-RRB- -RRB-) (NP (NN ANA) (NNS titres)) (PP-LOC (IN in) (NP (NP (NML (NN C57BL) (HYPH /) (CD 6)) (NNS mice)) (, ,) (NP (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (, ,) (CC and) (NP (NML (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (CD 129)) (-LRB- -LRB-) (NML (NML (NN D1Mit105)) (PP (SYM –) (NP (CD 223))))) (-RRB- -RRB-) (JJ congenic) (NNS mice)))) (PP-TMP (IN at) (NP (NP (CD 1) (NN y)) (PP (IN of) (NP (NN age))))) (. .))) )
( (CAPTION (S (S (S (NP-SBJ=2 (JJ Small) (NNS symbols)) (VP (VBP represent) (NP=1 (CD one) (NN mouse)))) (: ;) (S (NP-SBJ=2 (JJ large) (NNS symbols)) (, ,) (NP=1 (NP (DT a) (JJ variable) (NN number)) (PP (IN of) (NP (NNS animals)))))) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN indicated) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (NNS parentheses)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Serum) (NN sample)) (VP (VBD were) (VP (VBN titrated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN endpoint))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (LST (LS B) (CC and) (LS C)) (-RRB- -RRB-) (NP (ADJP (ADJP (NN Anti-ssDNA) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))) (CC and) (ADJP (JJ anti-chromatin) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))) (NN Ab) (NNS levels)) (PP-LOC (IN in) (NP (NP (DT the) (JJ same) (NNS cohorts)) (PP (IN of) (NP (NNS mice))) (PP (IN as) (PP (IN in) (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NN Ab) (NNS levels)) (VP (VBP are) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS AEUs)) (ADJP (JJ related) (PP (IN to) (NP (NP (DT a) (JJ standard) (JJ positive) (NN sample)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD was) (VP (VBN assigned) (NP-2 (-NONE- *)) (NP (NP (DT a) (NN value)) (PP (IN of) (NP (CD 100) (NN AEU))))))))))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NML (JJ Anti-dsDNA) (NN Ab)) (NNS levels) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Serum) (NNS samples)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 20))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Samples)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ positive)))))) (VP (VBD were) (VP (VBN titrated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN endpoint))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NNS symbols)) (VP (VBP are) (PP-PRD (IN as) (PP (IN in) (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 9))) )
( (CAPTION (NP (JJ Renal) (JJ Histological) (NN Assessment))) )
( (CAPTION (S (NP-SBJ-1 (NP (NML (NN C57BL) (HYPH /) (CD 6)) (NNS mice)) (, ,) (NP (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS mice)) (, ,) (CC and) (NP (NML (NML (NML (NN C57BL) (HYPH /) (CD 6)) (HYPH .) (CD 129)) (-LRB- -LRB-) (NML (NML (NN D1Mit105)) (PP (SYM –) (NP (CD 223)))) (-RRB- -RRB-)) (JJ congenic) (NNS mice))) (VP (VBD were) (VP (VBN sacrificed) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (NP (CD 1) (NN y)) (PP (IN of) (NP (NN age))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB obtain) (NP (ADJP (NN age) (HYPH -) (VBN matched)) (NN autopsy) (NNS specimens))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNP Bouin) (POS 's)) (NML (VBN fixed) (NN kidney)) (NNS sections)) (VP (VBD were) (VP (VBN scored) (NP-1 (-NONE- *)) (ADVP-MNR (RB blinded)) (PP-PRP (IN for) (NP (NN glomerulonephritis))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Glomerulonephritis)) (VP (VBD was) (VP (VBN graded) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NML (CD 0)) (PP (SYM –) (NP (CD 3)))) (NN scale))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)) (PP-PRP (IN for) (NP (NNS details))))) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (CAPTION (NP (NP (NN Linkage)) (PP (IN of) (NP (NN Chromosome) (CD 8))) (PP (IN with) (NP (ADJP (JJ Anti-Chromatin) (CC and) (JJ Anti-dsDNA)) (NNS Abs))) (PP-LOC (IN in) (NP (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2) (NNS Mice))))) )
( (CAPTION (S (NP-SBJ-1 (DT These) (NNS linkages)) (VP (VBD were) (RB not) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (-LRB- -LRB-) (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)) (HYPH .) (NML (NN Apcs) (SYM −) (HYPH /) (SYM −))) (NNS animals))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Centimorgan) (NNS positions)) (VP (VBD were) (VP (VBN deduced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN interval) (NN mapping))) (, ,) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG anchoring) (NP (NN marker) (NNS locations)) (PP (IN to) (NP (NP (NNS data)) (PP (IN from) (NP (NN http://www.informatics.jax.org))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Dotted) (NNS lines)) (VP (VBP indicate) (NP (NP (DT the) (NN threshold)) (SBAR (WHPP-2 (IN over) (WHNP (WDT which))) (S (NP-SBJ-1 (NN linkage)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ suggestive))) (PP-2 (-NONE- *T*))))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN defined) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (NNS Materials) (CC and) (NNS Methods))))))) (. .))) )
( (HEADING (NP (NN Table) (CD 1))) )
( (CAPTION (NP (NP (JJ Spontaneous) (NNS Auto-Abs)) (PP-LOC (IN in) (NP (NML (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (CC and) (NML (NML (JJ Wild) (HYPH -) (NN Type)) (-LRB- -LRB-) (NML (NML (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)))) (JJ Female) (NNS Mice))))) )
( (CAPTION (NP (NP (JJ Significant) (NNS differences)) (PP (IN between) (NP (NML (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS controls))) (PP (IN by) (NP (NML (NNP Mann) (HYPH –) (NNP Whitney)) (NNP U) (NN test))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NNS numbers)) (VP (VBN tested) (NP (-NONE- *)) (PP-PRP (IN for) (NP (JJ different) (NNS phenotypes))))) (VP (VBP are) (RB not) (ADJP-PRD (JJ equal)) (PP-PRP (IN due) (IN to) (NP (NP (NP (DT the) (VBN limited) (NN amount)) (PP (IN of) (NP (NN serum)))) (CC or) (NP (NP (NN death)) (PP (IN of) (NP (DT the) (NNS mice))) (PP-TMP (IN before) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN experiment))))))))) (. .))) )
( (CAPTION (NP (NP (JJ NS)) (, ,) (NP (RB not) (JJ significant)))) )
( (HEADING (NP (NN Table) (CD 2))) )
( (CAPTION (NP (NP (JJ Histological) (NN Assessment)) (PP (IN of) (NP (NN Kidney) (NNS Sections))) (PP-LOC (IN in) (NP (NML (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (CC and) (NML (JJ Wild) (HYPH -) (NN Type))) (NML (-LRB- -LRB-) (NML (CD 129)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6)) (-RRB- -RRB-)) (NN F2) (JJ Female) (NNS Mice))))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (JJ renal) (NNS sections)) (VP (VBD were) (VP (VBN scored) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NML (CD 0)) (PP (SYM –) (NP (CD 3)))) (NN scale))) (PP (IN on) (NP (NP (DT the) (NML (NN intensity) (CC and) (NN extent))) (PP (IN of) (NP (DT the) (JJ histopathological) (NNS changes))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (PP (IN in) (NP (NNS Materials) (CC and) (NNS Methods)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NN difference)) (PP (IN between) (NP (DT the) (CD two) (JJ experimental) (NNS groups)))) (VP (VBD was) (RB not) (ADJP-PRD (JJ significant))))) )
( (HEADING (NP (NN Table) (CD 3))) )
( (CAPTION (NP (NP (NN Summary)) (PP (IN of) (NP (NP (ADJP (NN Genome) (HYPH -) (JJ Wide)) (NN Linkage) (NN Analysis)) (PP-LOC (IN in) (NP (NML (NML (NN Apcs) (SYM −) (HYPH /) (SYM −)) (CC and) (NML (NML (JJ Wild) (HYPH -) (NN Type)) (-LRB- -LRB-) (NML (NML (CD 129) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (-RRB- -RRB-) (NN F2)))) (JJ Female) (NNS Mice))))))) )
( (CAPTION (NP (LST (LS a)) (:  ) (JJ Suggestive) (NN linkage))) )
( (CAPTION (NP (LST (LS b)) (:  ) (JJ Significant) (NN linkage))) )
( (CAPTION (NP (LST (LS c)) (:  ) (NP (ADJP (RB Highly) (JJ significant)) (NN linkage)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN defined) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN material) (CC and) (NN method)) (NN section)))))))) )
( (CAPTION (NP (NP (NP (NN Chr)) (, ,) (NP (NN Chromosome))) (: ;) (NP (NP (VBN Est.) (NN Peak)) (, ,) (NP (VBN Estimated) (NN Peak))) (: ;) (NP (NP (NN LOD)) (, ,) (NP (NP (NN logarithm)) (PP (IN of) (NP (NNS odds))))) (: ;) (NP (NP (NN N) (HYPH /) (NN A)) (, ,) (S-TTL (NP-SBJ (-NONE- *PRO*)) (RB not) (ADJP-PRD (JJ applicable)))))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Chromosomes)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (NNS linkages)) (VP (VBD were) (RB not) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (CC both) (JJ experimental) (NNS groups))) (ADVP-LOC-2 (-NONE- *T*)))))) (VP (VBP are) (RB not) (VP (VBN illustrated) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB See) (NP (NNS Materials) (CC and) (NNS Methods)) (PP-PRP (IN for) (NP (NNS details)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NML (NML (NN oligonucleotide) (NNS sequences)) (CC and) (NML (NP (JJ approximate) (NNS positions)) (PP (IN of) (NP (NP (DT the) (NN microsatellite) (NNS markers)) (VP (VBN used) (NP (-NONE- *)))))))) (VP (VBD were) (VP (VBN taken) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NNP Mouse) (NNP Genome) (NNP Database)) (, ,) (NP-ADV (NP (NNP Mouse) (NNP Genome) (NNP Informatics)) (, ,) (NP-LOC (NNP Jackson) (NNP Laboratory)) (, ,) (NP-LOC (NNP Bar) (NNP Harbor)) (, ,) (NP-LOC (NNP Maine)) (, ,) (NP-LOC (NNP United) (NNP States))) (PRN (-LRB- -LRB-) (NP (NN http://www.informatics.jax.org)) (-RRB- -RRB-)))))))) )
( (HEADING (NP (NNS Footnotes))) )
( (CAPTION (NP (NP (NNS Conflicts)) (PP (IN of) (NP (NN interest))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN declared) (SBAR (IN that) (S (NP-SBJ (NP (DT no) (NNS conflicts)) (PP (IN of) (NP (NN interest)))) (VP (VBP exist)))))) (. .))) )
( (HEADING (NP (NN Author) (NNS contributions) (. .))) )
( (S (NP-SBJ (NNP MJW) (, ,) (NNP TJV) (, ,) (CC and) (NNP MB)) (VP (VBD conceived) (CC and) (VBD designed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NP (NNP AEB)) (, ,) (NP (NNP KLR)) (, ,) (NP (NNP JW)) (, ,) (NP (NNP JC) (HYPH -) (NNP H)) (, ,) (CC and) (NP (NNP RJR))) (VP (VBD performed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP AEB) (, ,) (NNP KLR) (, ,) (NNP RJR) (, ,) (CC and) (NNP HTC)) (VP (VBD analyzed) (NP (DT the) (NNS data))) (. .)) )
( (S (NP-SBJ (NNP MB)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (FRAG (NP-SBJ (JJ Academic) (NN Editor)) (: :) (NP-PRD (NP (NNP David) (NNP Nemazee)) (, ,) (NP-LOC (NNP Scripps) (NNP Research) (NNP Institute)))) )
( (FRAG (SYM ¤) (NP-SBJ (JJ Current) (NN address)) (: :) (NP-PRD (NP (DT The) (NNP Wellcome) (NNP Trust)) (, ,) (NP-LOC (NNP London)) (, ,) (NP-LOC (NNP United) (NNP Kingdom)))) )
( (FRAG (NP (NN Citation)) (: :) (CIT (NNP Bygrave) (NNP AE) (, ,) (NNP Rose) (NNP KL) (, ,) (NNP Cortes) (HYPH -) (NNP Hernandez) (NNP J) (, ,) (NNP Warren) (NNP J) (, ,) (NNP Rigby) (NNP RJ) (, ,) (FW et) (FW al.) (-LRB- -LRB-) (CD 2004) (-RRB- -RRB-) (JJ Spontaneous) (NN autoimmunity) (IN in) (CD 129) (CC and) (NN C57BL) (HYPH /) (CD 6) (NNS mice) (: —) (NNS Implications) (IN for) (NN autoimmunity) (VBN described) (IN in) (NN gene) (HYPH -) (VBN targeted) (NNS mice)) (. .)) )
( (CIT (NNP PLoS) (NNP Biol) (CD 2) (-LRB- -LRB-) (CD 8) (-RRB- -RRB-) (: :) (NN e243) (. .)) )
